<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bull World Health Organ</journal-id><journal-id journal-id-type="iso-abbrev">Bull. World Health Organ</journal-id><journal-id journal-id-type="publisher-id">BLT</journal-id><journal-title-group><journal-title>Bulletin of the World Health Organization</journal-title></journal-title-group><issn pub-type="ppub">0042-9686</issn><issn pub-type="epub">1564-0604</issn><publisher><publisher-name>World Health Organization</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29962550</article-id><article-id pub-id-type="pmc">6022611</article-id><article-id pub-id-type="publisher-id">BLT.18.208959</article-id><article-id pub-id-type="doi">10.2471/BLT.18.208959</article-id><article-categories><subj-group subj-group-type="heading"><subject>Systematic Reviews</subject></subj-group></article-categories><title-group><article-title>Cash interventions to improve clinical outcomes for pulmonary tuberculosis: systematic review and meta-analysis</article-title><trans-title-group xml:lang="fr"><trans-title xml:lang="fr">Des interventions financi&#x000e8;res pour am&#x000e9;liorer les r&#x000e9;sultats cliniques de la tuberculose pulmonaire: revue syst&#x000e9;matique et m&#x000e9;ta-analyse</trans-title></trans-title-group><trans-title-group xml:lang="es"><trans-title xml:lang="es">Intervenciones de efectivo para mejorar los resultados cl&#x000ed;nicos de la tuberculosis pulmonar: revisi&#x000f3;n sistem&#x000e1;tica y metan&#x000e1;lisis</trans-title></trans-title-group><trans-title-group xml:lang="ar"><trans-title xml:lang="ar"> &#x00627;&#x00644;&#x0062a;&#x0062f;&#x0062e;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00646;&#x00642;&#x0062f;&#x0064a;&#x00629; &#x00644;&#x0062a;&#x0062d;&#x00633;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; &#x00627;&#x00644;&#x00633;&#x00631;&#x0064a;&#x00631;&#x0064a;&#x00629; &#x00644;&#x00645;&#x00631;&#x00636; &#x00627;&#x00644;&#x00633;&#x00644; &#x00627;&#x00644;&#x00631;&#x00626;&#x00648;&#x0064a;: &#x00645;&#x00631;&#x00627;&#x0062c;&#x00639;&#x00629; &#x00645;&#x00646;&#x00647;&#x0062c;&#x0064a;&#x00629; &#x00648;&#x0062a;&#x0062d;&#x00644;&#x0064a;&#x00644; </trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title xml:lang="zh">&#x0901a;&#x08fc7;&#x073b0;&#x091d1;&#x05e72;&#x09884;&#x04ee5;&#x06539;&#x05584;&#x080ba;&#x07ed3;&#x06838;&#x07684;&#x04e34;&#x05e8a;&#x07597;&#x06548;&#x0ff1a;&#x07cfb;&#x07edf;&#x08bc4;&#x04ef7;&#x0548c;&#x0835f;&#x08403;&#x05206;&#x06790;</trans-title></trans-title-group><trans-title-group xml:lang="ru"><trans-title xml:lang="ru">&#x00424;&#x00438;&#x0043d;&#x00430;&#x0043d;&#x00441;&#x0043e;&#x00432;&#x00430;&#x0044f; &#x0043f;&#x0043e;&#x0043c;&#x0043e;&#x00449;&#x0044c; &#x0043a;&#x00430;&#x0043a; &#x00441;&#x00440;&#x00435;&#x00434;&#x00441;&#x00442;&#x00432;&#x0043e; &#x00443;&#x0043b;&#x00443;&#x00447;&#x00448;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x0043a;&#x0043b;&#x00438;&#x0043d;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438;&#x00445; &#x00438;&#x00441;&#x00445;&#x0043e;&#x00434;&#x0043e;&#x00432; &#x0043b;&#x00435;&#x00447;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00442;&#x00443;&#x00431;&#x00435;&#x00440;&#x0043a;&#x00443;&#x0043b;&#x00435;&#x00437;&#x00430; &#x0043b;&#x00435;&#x00433;&#x0043a;&#x00438;&#x00445;: &#x00441;&#x00438;&#x00441;&#x00442;&#x00435;&#x0043c;&#x00430;&#x00442;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438;&#x00439; &#x0043e;&#x00431;&#x00437;&#x0043e;&#x00440; &#x00438; &#x0043c;&#x00435;&#x00442;&#x00430;&#x00430;&#x0043d;&#x00430;&#x0043b;&#x00438;&#x00437;</trans-title></trans-title-group><alt-title alt-title-type="author-running-head">Aaron Richterman et al.</alt-title><alt-title alt-title-type="title-running-head">Cash interventions to improve tuberculosis outcomes</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Richterman</surname><given-names>Aaron</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Steer-Massaro</surname><given-names>Jonathan</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jarolimova</surname><given-names>Jana</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Luong Nguyen</surname><given-names>Liem Binh</given-names></name><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><contrib contrib-type="author"><name><surname>Werdenberg</surname><given-names>Jennifer</given-names></name><xref ref-type="aff" rid="aff5"><sup>e</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ivers</surname><given-names>Louise C</given-names></name><xref ref-type="aff" rid="aff6"><sup>f</sup></xref></contrib><aff id="aff1"><label>a</label>Department of Medicine, Brigham and Women&#x02019;s Hospital, 75 Francis Street, Boston, MA 02115, United States of America (USA).</aff><aff id="aff2"><label>b</label>Department of Obstetrics and Gynecology, <institution>Boston University School of Medicine</institution>, <addr-line>Boston</addr-line>, <country>USA</country>.</aff><aff id="aff3"><label>c</label>Department of Medicine, <institution>Massachusetts General Hospital</institution>, <addr-line>Boston</addr-line>, <country>USA</country>.</aff><aff id="aff4"><label>d</label>Infection, Antimicrobials, Modelling and Evolution, Unit&#x000e9; Mixte de Recherche 1137, INSERM, <addr-line>Paris</addr-line>, <country>France</country>.</aff><aff id="aff5"><label>e</label>Department of Pediatrics, <institution>Dell Children&#x02019;s Hospital</institution>, <addr-line>Austin</addr-line>, <country>USA</country>.</aff><aff id="aff6"><label>f</label>Center for Global Health, <institution>Massachusetts General Hospital</institution>, <addr-line>Boston</addr-line>, <country>USA</country>.</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to Aaron Richterman (email: <email xlink:href="arichterman@partners.org">arichterman@partners.org</email>).</corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>7</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>04</day><month>6</month><year>2018</year></pub-date><volume>96</volume><issue>7</issue><fpage>471</fpage><lpage>483</lpage><history><date date-type="received"><day>24</day><month>1</month><year>2018</year></date><date date-type="rev-recd"><day>26</day><month>4</month><year>2018</year></date><date date-type="accepted"><day>30</day><month>4</month><year>2018</year></date></history><permissions><copyright-statement>(c) 2018 The authors; licensee World Health Organization.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/igo/legalcode">http://creativecommons.org/licenses/by/3.0/igo/legalcode</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.</license-p></license></permissions><abstract><title>Abstract</title><sec><title>Objective</title><p>To assess cash transfer interventions for improving treatment outcomes of active pulmonary tuberculosis in low- and middle-income countries.</p></sec><sec><title>Methods</title><p>We searched PubMed&#x000ae;, Embase&#x000ae;, Cochrane Library and ClinicalTrials.gov for studies published until 4 August 2017 that reported on cash transfer interventions during the treatment of active pulmonary tuberculosis in low- and middle-income countries. Our primary outcome was a positive clinical outcome, defined as treatment success, treatment completion or microbiologic cure. Using the purchasing power parity conversion factor, we converted the amount of cash received per patient within each study into international dollars (Int$). We calculated odds ratio (OR) for the primary outcome using a random effects meta-analysis.</p></sec><sec><title>Findings</title><p>Eight studies met eligibility criteria for review inclusion. Seven studies assessed a tuberculosis-specific intervention, with average amount of cash ranging from Int$&#x000a0;193&#x02013;858. One study assessed a tuberculosis-sensitive intervention, with average amount of Int$&#x000a0;101. Four studies included non-cash co-interventions. All studies showed better primary outcome for the intervention group than the control group. After excluding three studies with high risk of bias, patients receiving tuberculosis-specific cash transfer were more likely to have a positive clinical outcome than patients in the control groups (OR: 1.77; 95% confidence interval: 1.57&#x02013;2.01).</p></sec><sec><title>Conclusion</title><p>The evidence available suggests that patients in low- and middle-income countries receiving cash during treatment for active pulmonary tuberculosis are more likely to have a positive clinical outcome. These findings support the incorporation of cash transfer interventions into social protection schemes within tuberculosis treatment programmes.</p></sec></abstract><trans-abstract xml:lang="fr"><title>R&#x000e9;sum&#x000e9;</title><sec><title>Objectif</title><p>&#x000c9;valuer le r&#x000f4;le des interventions de transfert de fonds pour am&#x000e9;liorer les r&#x000e9;sultats du traitement de la tuberculose pulmonaire active dans les pays &#x000e0; revenu faible et interm&#x000e9;diaire.</p></sec><sec><title>M&#x000e9;thodes</title><p>Nous avons recherch&#x000e9;, dans les bases de donn&#x000e9;es de PubMed&#x000ae;, d'Embase&#x000ae;, de ClinicalTrials.gov et de la Cochrane Library, des &#x000e9;tudes publi&#x000e9;es jusqu'au 4&#x000a0;ao&#x000fb;t 2017 qui mentionnaient des interventions de transfert de fonds durant le traitement de la tuberculose pulmonaire active dans des pays &#x000e0; revenu faible et interm&#x000e9;diaire. Le crit&#x000e8;re principal pris en compte &#x000e9;tait l'obtention d'un r&#x000e9;sultat clinique positif, d&#x000e9;fini comme la r&#x000e9;ussite du traitement, l'ach&#x000e8;vement du traitement ou la gu&#x000e9;rison microbiologique. &#x000c0; l'aide du taux de conversion en parit&#x000e9; de pouvoir d'achat, nous avons converti le montant des fonds vers&#x000e9;s par patient dans chaque &#x000e9;tude en dollars internationaux ($&#x000a0;int.). Nous avons calcul&#x000e9; le rapport des cotes (RC) pour le crit&#x000e8;re principal au moyen d'une m&#x000e9;ta-analyse &#x000e0; effets al&#x000e9;atoires.</p></sec><sec><title>R&#x000e9;sultats</title><p>Huit &#x000e9;tudes remplissaient les crit&#x000e8;res d'admissibilit&#x000e9; permettant d'&#x000ea;tre incluses dans notre revue. Sept &#x000e9;tudes &#x000e9;valuaient une intervention sp&#x000e9;cifique &#x000e0; la tuberculose, avec un montant moyen vers&#x000e9; compris entre 193 et 858&#x000a0;$&#x000a0;int. Une &#x000e9;tude &#x000e9;valuait une intervention prenant en compte la tuberculose, avec un montant moyen de 101&#x000a0;$&#x000a0;int. Quatre &#x000e9;tudes comprenaient des co-interventions non financi&#x000e8;res. Toutes les &#x000e9;tudes montraient un crit&#x000e8;re principal plus souvent atteint dans le groupe exp&#x000e9;rimental que dans le groupe t&#x000e9;moin. Apr&#x000e8;s avoir exclu trois &#x000e9;tudes qui pr&#x000e9;sentaient un risque de biais important, il est ressorti que les patients qui b&#x000e9;n&#x000e9;ficiaient de transferts de fonds sp&#x000e9;cifiques &#x000e0; la tuberculose &#x000e9;taient plus susceptibles d'avoir un r&#x000e9;sultat clinique positif que les patients des groupes t&#x000e9;moins (RC: 1,77; intervalle de confiance de 95%: 1,57-2,01).</p></sec><sec><title>Conclusion</title><p>Les donn&#x000e9;es disponibles sugg&#x000e8;rent que les patients des pays &#x000e0; revenu faible et interm&#x000e9;diaire qui re&#x000e7;oivent des sommes d'argent durant leur traitement contre la tuberculose pulmonaire active sont plus susceptibles d'avoir un r&#x000e9;sultat clinique positif. Ces conclusions vont dans le sens de l'int&#x000e9;gration d'interventions de transfert de fonds dans les plans de protection sociale des programmes de traitement de la tuberculose.</p></sec></trans-abstract><trans-abstract xml:lang="es"><title>Resumen</title><sec><title>Objetivo</title><p>Evaluar las intervenciones de transferencias de efectivo para mejorar los resultados del tratamiento de la tuberculosis pulmonar activa en los pa&#x000ed;ses con ingresos entre bajos y medios.</p></sec><sec><title>M&#x000e9;todos</title><p>Se realizaron b&#x000fa;squedas en PubMed&#x000ae;, Embase&#x000ae;, Cochrane Library y ClinicalTrials.gov en busca de estudios publicados hasta el 4 de agosto de 2017 que informaran sobre intervenciones de transferencias de efectivo durante el tratamiento de la tuberculosis pulmonar activa en pa&#x000ed;ses con ingresos entre bajos y medios. El resultado principal fue un resultado cl&#x000ed;nico positivo, definido como &#x000e9;xito del tratamiento, finalizaci&#x000f3;n del tratamiento o curaci&#x000f3;n microbiol&#x000f3;gica. Con el factor de conversi&#x000f3;n de paridad del poder adquisitivo, se convirti&#x000f3; la cantidad de dinero en efectivo recibido por paciente dentro de cada estudio en d&#x000f3;lares internacionales. Se calcul&#x000f3; el cociente de posibilidades (CP) para el resultado principal mediante un metan&#x000e1;lisis de efectos aleatorios.</p></sec><sec><title>Resultados</title><p>Ocho estudios cumplieron los criterios de elegibilidad para ser incluidos en la revisi&#x000f3;n. Siete estudios evaluaron una intervenci&#x000f3;n espec&#x000ed;fica para la tuberculosis, con una cantidad promedio de efectivo que oscil&#x000f3; entre 193 e 858 d&#x000f3;lares internacionales. Un estudio evalu&#x000f3; una intervenci&#x000f3;n sensible a la tuberculosis, con una cantidad promedio de 101 d&#x000f3;lares internacionales. Cuatro estudios inclu&#x000ed;an cointervenciones no monetarias. Todos los estudios mostraron mejores resultados principales para el grupo de intervenci&#x000f3;n que para el grupo control. Despu&#x000e9;s de excluir tres estudios con alto riesgo de sesgo, los pacientes que recibieron una transferencia de efectivo espec&#x000ed;fica para la tuberculosis tuvieron mayores probabilidades de obtener un resultado cl&#x000ed;nico positivo que los pacientes de los grupos control (CP: 1,77; intervalo de confianza (IC) del 95%: 1,57 a 2,01).</p></sec><sec><title>Conclusi&#x000f3;n</title><p>Las pruebas disponibles indican que los pacientes de pa&#x000ed;ses con ingresos entre bajos y medios que reciben dinero en efectivo durante el tratamiento de la tuberculosis pulmonar activa tienen m&#x000e1;s probabilidades de obtener un resultado cl&#x000ed;nico positivo. Estas conclusiones apoyan la incorporaci&#x000f3;n de las intervenciones de transferencias de efectivo en los planes de protecci&#x000f3;n social dentro de los programas para el tratamiento de la tuberculosis.</p></sec></trans-abstract><trans-abstract xml:lang="ar"><title>&#x00645;&#x00644;&#x0062e;&#x00635; </title><sec><title>&#x00627;&#x00644;&#x0063a;&#x00631;&#x00636; </title><p>&#x0062a;&#x00642;&#x0064a;&#x0064a;&#x00645; &#x0062a;&#x0062f;&#x0062e;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062a;&#x0062d;&#x00648;&#x0064a;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00646;&#x00642;&#x0062f;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00633;&#x00627;&#x00639;&#x0064a;&#x00629; &#x00625;&#x00644;&#x00649; &#x0062a;&#x0062d;&#x00633;&#x0064a;&#x00646; &#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; &#x00639;&#x00644;&#x00627;&#x0062c; &#x00627;&#x00644;&#x00633;&#x00644; &#x00627;&#x00644;&#x00631;&#x00626;&#x00648;&#x0064a; &#x00627;&#x00644;&#x00646;&#x00634;&#x00637; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00630;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062f;&#x0062e;&#x00644; &#x00627;&#x00644;&#x00645;&#x00646;&#x0062e;&#x00641;&#x00636; &#x00648;&#x00627;&#x00644;&#x00645;&#x0062a;&#x00648;&#x00633;&#x00637;. </p></sec><sec><title>&#x00627;&#x00644;&#x00637;&#x00631;&#x0064a;&#x00642;&#x00629; </title><p>&#x00644;&#x00642;&#x0062f; &#x00642;&#x00645;&#x00646;&#x00627; &#x00628;&#x00627;&#x00644;&#x00628;&#x0062d;&#x0062b; &#x00641;&#x0064a; &#x00643;&#x00644; &#x00645;&#x00646; PubMed&#x000ae;&#x0060c; &#x00648;Embase&#x000ae;&#x0060c; &#x00648;&#x00645;&#x00643;&#x0062a;&#x00628;&#x00629; Cochrane Library&#x0060c; &#x00648;ClinicalTrials.gov&#x0060c; &#x00639;&#x00646; &#x00627;&#x00644;&#x0062f;&#x00631;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x00646;&#x00634;&#x00648;&#x00631;&#x00629; &#x0062d;&#x0062a;&#x00649; 4 &#x00623;&#x0063a;&#x00633;&#x00637;&#x00633;/&#x00622;&#x00628; 2017&#x0060c; &#x00648;&#x00627;&#x00644;&#x0062a;&#x0064a; &#x0062a;&#x00646;&#x00627;&#x00648;&#x00644;&#x0062a; &#x0062a;&#x0062f;&#x0062e;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062a;&#x0062d;&#x00648;&#x0064a;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00646;&#x00642;&#x0062f;&#x0064a;&#x00629; &#x00623;&#x0062b;&#x00646;&#x00627;&#x00621; &#x00639;&#x00644;&#x00627;&#x0062c; &#x00627;&#x00644;&#x00633;&#x00644; &#x00627;&#x00644;&#x00631;&#x00626;&#x00648;&#x0064a; &#x00627;&#x00644;&#x00646;&#x00634;&#x00637; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00630;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062f;&#x0062e;&#x00644; &#x00627;&#x00644;&#x00645;&#x00646;&#x0062e;&#x00641;&#x00636; &#x00648;&#x00627;&#x00644;&#x00645;&#x0062a;&#x00648;&#x00633;&#x00637;. &#x00648;&#x00643;&#x00627;&#x00646;&#x0062a; &#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c;&#x00646;&#x00627; &#x00627;&#x00644;&#x00623;&#x00648;&#x00644;&#x0064a;&#x00629; &#x00646;&#x0062a;&#x0064a;&#x0062c;&#x00629; &#x00633;&#x00631;&#x0064a;&#x00631;&#x0064a;&#x00629; &#x00625;&#x0064a;&#x0062c;&#x00627;&#x00628;&#x0064a;&#x00629;&#x0060c; &#x0062a;&#x00645; &#x0062a;&#x00639;&#x00631;&#x0064a;&#x00641;&#x00647;&#x00627; &#x00628;&#x00623;&#x00646;&#x00647;&#x00627; &#x00646;&#x0062c;&#x00627;&#x0062d; &#x00627;&#x00644;&#x00639;&#x00644;&#x00627;&#x0062c;&#x0060c; &#x00623;&#x00648; &#x00625;&#x00643;&#x00645;&#x00627;&#x00644; &#x00627;&#x00644;&#x00639;&#x00644;&#x00627;&#x0062c;&#x0060c; &#x00623;&#x00648; &#x00627;&#x00644;&#x0062a;&#x00639;&#x00627;&#x00641;&#x0064a; &#x00627;&#x00644;&#x00645;&#x0064a;&#x00643;&#x00631;&#x00648;&#x00628;&#x0064a;&#x00648;&#x00644;&#x00648;&#x0062c;&#x0064a;. &#x00648;&#x00628;&#x00627;&#x00633;&#x0062a;&#x0062e;&#x0062f;&#x00627;&#x00645; &#x00645;&#x00639;&#x00627;&#x00645;&#x00644; &#x0062a;&#x0062d;&#x00648;&#x0064a;&#x00644; &#x0062a;&#x00639;&#x00627;&#x0062f;&#x00644; &#x00627;&#x00644;&#x00642;&#x00648;&#x00629; &#x00627;&#x00644;&#x00634;&#x00631;&#x00627;&#x00626;&#x0064a;&#x00629;&#x0060c; &#x00642;&#x00645;&#x00646;&#x00627; &#x00628;&#x0062a;&#x0062d;&#x00648;&#x0064a;&#x00644; &#x00627;&#x00644;&#x00645;&#x00628;&#x00644;&#x0063a; &#x00627;&#x00644;&#x00646;&#x00642;&#x0062f;&#x0064a; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00644;&#x00645; &#x00644;&#x00643;&#x00644; &#x00645;&#x00631;&#x0064a;&#x00636; &#x00641;&#x0064a; &#x00643;&#x00644; &#x0062f;&#x00631;&#x00627;&#x00633;&#x00629; &#x00625;&#x00644;&#x00649; &#x0062f;&#x00648;&#x00644;&#x00627;&#x00631; &#x0062f;&#x00648;&#x00644;&#x0064a;. &#x0062d;&#x00633;&#x00628;&#x00646;&#x00627; &#x00646;&#x00633;&#x00628;&#x00629; &#x00627;&#x00644;&#x00627;&#x0062d;&#x0062a;&#x00645;&#x00627;&#x00644; (OR) &#x00644;&#x00644;&#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; &#x00627;&#x00644;&#x00623;&#x00648;&#x00644;&#x0064a;&#x00629; &#x00628;&#x00627;&#x00633;&#x0062a;&#x0062e;&#x0062f;&#x00627;&#x00645; &#x00627;&#x00644;&#x0062a;&#x0062d;&#x00644;&#x0064a;&#x00644; &#x00627;&#x00644;&#x0062a;&#x00644;&#x00648;&#x0064a; &#x00627;&#x00644;&#x00639;&#x00634;&#x00648;&#x00627;&#x00626;&#x0064a;. </p></sec><sec><title>&#x00627;&#x00644;&#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; </title><p>&#x0062a;&#x00648;&#x00627;&#x00641;&#x00642;&#x0062a; &#x0062b;&#x00645;&#x00627;&#x00646;&#x0064a; &#x0062f;&#x00631;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00645;&#x00639; &#x00645;&#x00639;&#x00627;&#x0064a;&#x0064a;&#x00631; &#x00627;&#x00644;&#x00623;&#x00647;&#x00644;&#x0064a;&#x00629; &#x00644;&#x0062a;&#x00636;&#x00645;&#x0064a;&#x00646;&#x00647;&#x00627; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00645;&#x00631;&#x00627;&#x0062c;&#x00639;&#x00629;. &#x00642;&#x00627;&#x00645;&#x0062a; &#x00633;&#x00628;&#x00639; &#x0062f;&#x00631;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00628;&#x0062a;&#x00642;&#x0064a;&#x0064a;&#x00645; &#x00627;&#x00644;&#x0062a;&#x0062f;&#x0062e;&#x00644; &#x00627;&#x00644;&#x0062e;&#x00627;&#x00635; &#x00628;&#x00645;&#x00631;&#x00636; &#x00627;&#x00644;&#x00633;&#x00644;&#x0060c; &#x00645;&#x00639; &#x00645;&#x0062a;&#x00648;&#x00633;&#x00637; &#x00645;&#x00628;&#x00644;&#x0063a; &#x00646;&#x00642;&#x0062f;&#x0064a; &#x0064a;&#x0062a;&#x00631;&#x00627;&#x00648;&#x0062d; &#x00645;&#x00646; 193 &#x00625;&#x00644;&#x00649; 858 &#x0062f;&#x00648;&#x00644;&#x00627;&#x00631;&#x00627;&#x0064b; &#x0062f;&#x00648;&#x00644;&#x0064a;&#x00627;&#x0064b;. &#x00648;&#x00642;&#x0064a;&#x00645;&#x0062a; &#x00625;&#x0062d;&#x0062f;&#x00649; &#x00627;&#x00644;&#x0062f;&#x00631;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062a;&#x0062f;&#x0062e;&#x00644; &#x00627;&#x00644;&#x0062d;&#x00633;&#x00627;&#x00633; &#x00644;&#x00645;&#x00631;&#x00636; &#x00627;&#x00644;&#x00633;&#x00644;&#x0060c; &#x00628;&#x00645;&#x0062a;&#x00648;&#x00633;&#x00637; &#x00645;&#x00628;&#x00644;&#x0063a; &#x00642;&#x0062f;&#x00631;&#x00647; 101 &#x0062f;&#x00648;&#x00644;&#x00627;&#x00631;&#x00627;&#x0064b; &#x0062f;&#x00648;&#x00644;&#x0064a;&#x00627;&#x0064b;. &#x00634;&#x00645;&#x00644;&#x0062a; &#x00623;&#x00631;&#x00628;&#x00639; &#x0062f;&#x00631;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062a;&#x0062f;&#x0062e;&#x00644;&#x00627;&#x0062a; &#x0063a;&#x0064a;&#x00631; &#x00627;&#x00644;&#x00646;&#x00642;&#x0062f;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00645;&#x00634;&#x0062a;&#x00631;&#x00643;&#x00629;. &#x00623;&#x00638;&#x00647;&#x00631;&#x0062a; &#x0062c;&#x00645;&#x0064a;&#x00639; &#x00627;&#x00644;&#x0062f;&#x00631;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; &#x00623;&#x00648;&#x00644;&#x0064a;&#x00629; &#x00623;&#x00641;&#x00636;&#x00644; &#x00644;&#x00645;&#x0062c;&#x00645;&#x00648;&#x00639;&#x00629; &#x00627;&#x00644;&#x0062a;&#x0062f;&#x0062e;&#x00644; &#x00645;&#x00646; &#x00627;&#x00644;&#x00645;&#x0062c;&#x00645;&#x00648;&#x00639;&#x00629; &#x00627;&#x00644;&#x00645;&#x00631;&#x0062c;&#x00639;&#x0064a;&#x00629;. &#x00628;&#x00639;&#x0062f; &#x00627;&#x00633;&#x0062a;&#x00628;&#x00639;&#x00627;&#x0062f; &#x0062b;&#x00644;&#x00627;&#x0062b; &#x0062f;&#x00631;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00630;&#x00627;&#x0062a; &#x0062e;&#x00637;&#x00648;&#x00631;&#x00629; &#x00639;&#x00627;&#x00644;&#x0064a;&#x00629; &#x00644;&#x00644;&#x0062a;&#x0062d;&#x0064a;&#x00632;&#x0060c; &#x00643;&#x00627;&#x00646; &#x00627;&#x00644;&#x00645;&#x00631;&#x00636;&#x00649; &#x00627;&#x00644;&#x00630;&#x0064a;&#x00646; &#x0064a;&#x0062a;&#x00644;&#x00642;&#x00648;&#x00646; &#x0062a;&#x0062d;&#x00648;&#x0064a;&#x00644;&#x00627;&#x0062a; &#x00646;&#x00642;&#x0062f;&#x0064a;&#x00629; &#x0062e;&#x00627;&#x00635;&#x00629; &#x00628;&#x00627;&#x00644;&#x00633;&#x00644; &#x00623;&#x00643;&#x0062b;&#x00631; &#x00639;&#x00631;&#x00636;&#x00629; &#x00644;&#x0062a;&#x0062d;&#x00642;&#x0064a;&#x00642; &#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; &#x00633;&#x00631;&#x0064a;&#x00631;&#x0064a;&#x00629; &#x00625;&#x0064a;&#x0062c;&#x00627;&#x00628;&#x0064a;&#x00629; &#x00645;&#x00646; &#x00627;&#x00644;&#x00645;&#x00631;&#x00636;&#x00649; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00645;&#x0062c;&#x00645;&#x00648;&#x00639;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x00631;&#x0062c;&#x00639;&#x0064a;&#x00629; (&#x00646;&#x00633;&#x00628;&#x00629; &#x00627;&#x00644;&#x00623;&#x00631;&#x0062c;&#x0062d;&#x0064a;&#x00629;: 1.77&#x0061b; &#x00641;&#x00627;&#x00635;&#x00644; &#x00627;&#x00644;&#x0062b;&#x00642;&#x00629; 95&#x0066a;: &#x00645;&#x00646; 1.57 &#x00625;&#x00644;&#x00649; 2.01). </p></sec><sec><title>&#x00627;&#x00644;&#x00627;&#x00633;&#x0062a;&#x00646;&#x0062a;&#x00627;&#x0062c; </title><p>&#x0062a;&#x00634;&#x0064a;&#x00631; &#x00627;&#x00644;&#x00623;&#x0062f;&#x00644;&#x00629; &#x00627;&#x00644;&#x00645;&#x0062a;&#x00627;&#x0062d;&#x00629; &#x00625;&#x00644;&#x00649; &#x00623;&#x00646; &#x00627;&#x00644;&#x00645;&#x00631;&#x00636;&#x00649; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00630;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062f;&#x0062e;&#x00644; &#x00627;&#x00644;&#x00645;&#x00646;&#x0062e;&#x00641;&#x00636; &#x00648;&#x00627;&#x00644;&#x00645;&#x0062a;&#x00648;&#x00633;&#x00637; &#x0060c; &#x00627;&#x00644;&#x00630;&#x0064a;&#x00646; &#x0064a;&#x0062a;&#x00644;&#x00642;&#x00648;&#x00646; &#x00645;&#x00628;&#x00627;&#x00644;&#x0063a; &#x00646;&#x00642;&#x0062f;&#x0064a;&#x00629; &#x00623;&#x0062b;&#x00646;&#x00627;&#x00621; &#x00639;&#x00644;&#x00627;&#x0062c;&#x00647;&#x00645; &#x00645;&#x00646; &#x00645;&#x00631;&#x00636; &#x00627;&#x00644;&#x00633;&#x00644; &#x00627;&#x00644;&#x00631;&#x00626;&#x00648;&#x0064a; &#x00627;&#x00644;&#x00646;&#x00634;&#x00637;&#x0060c; &#x00647;&#x00645; &#x00623;&#x00643;&#x0062b;&#x00631; &#x00639;&#x00631;&#x00636;&#x00629; &#x00644;&#x0062a;&#x0062d;&#x00642;&#x0064a;&#x00642; &#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; &#x00633;&#x00631;&#x0064a;&#x00631;&#x0064a;&#x00629; &#x00625;&#x0064a;&#x0062c;&#x00627;&#x00628;&#x0064a;&#x00629;. &#x0062a;&#x0062f;&#x00639;&#x00645; &#x00647;&#x00630;&#x00647; &#x00627;&#x00644;&#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; &#x00627;&#x00644;&#x00627;&#x0062a;&#x0062c;&#x00627;&#x00647; &#x00644;&#x0062f;&#x00645;&#x0062c; &#x0062a;&#x0062f;&#x0062e;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062a;&#x0062d;&#x00648;&#x0064a;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00646;&#x00642;&#x0062f;&#x0064a;&#x00629; &#x00641;&#x0064a; &#x00646;&#x00638;&#x00645; &#x00627;&#x00644;&#x0062d;&#x00645;&#x00627;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00627;&#x0062c;&#x0062a;&#x00645;&#x00627;&#x00639;&#x0064a;&#x00629; &#x00636;&#x00645;&#x00646; &#x00628;&#x00631;&#x00627;&#x00645;&#x0062c; &#x00639;&#x00644;&#x00627;&#x0062c; &#x00645;&#x00631;&#x00636; &#x00627;&#x00644;&#x00633;&#x00644;. </p></sec></trans-abstract><trans-abstract xml:lang="zh"><title>&#x06458;&#x08981;</title><sec><title>&#x076ee;&#x07684;</title><p>&#x08bc4;&#x04f30;&#x0901a;&#x08fc7;&#x073b0;&#x091d1;&#x08f6c;&#x079fb;&#x05e72;&#x09884;&#x063aa;&#x065bd;&#x04ee5;&#x06539;&#x05584;&#x04e2d;&#x04f4e;&#x06536;&#x05165;&#x056fd;&#x05bb6;&#x06d3b;&#x052a8;&#x06027;&#x080ba;&#x07ed3;&#x06838;&#x07684;&#x06cbb;&#x07597;&#x06548;&#x0679c;&#x03002;</p></sec><sec><title>&#x065b9;&#x06cd5;</title><p>&#x05728;&#x000a0;PubMed&#x000ae;&#x03001;Embase&#x000ae;&#x03001;&#x08003;&#x0514b;&#x05170;&#x056fe;&#x04e66;&#x09986;&#x0548c;&#x07f8e;&#x056fd;&#x04e34;&#x05e8a;&#x08bd5;&#x09a8c;&#x06570;&#x0636e;&#x05e93;&#x000a0;(ClinicalTrials.gov)&#x000a0;&#x0641c;&#x07d22;&#x0622a;&#x081f3;&#x000a0;2017&#x000a0;&#x05e74;&#x000a0;8&#x000a0;&#x06708;&#x000a0;4&#x000a0;&#x065e5;&#x053d1;&#x08868;&#x07684;&#x07814;&#x07a76;&#x065f6;&#x0ff0c;&#x06211;&#x04eec;&#x053d1;&#x073b0;&#x04e86;&#x062a5;&#x09053;&#x07684;&#x04e2d;&#x04f4e;&#x06536;&#x05165;&#x056fd;&#x05bb6;&#x06d3b;&#x052a8;&#x06027;&#x080ba;&#x07ed3;&#x06838;&#x06cbb;&#x07597;&#x0671f;&#x095f4;&#x07684;&#x073b0;&#x091d1;&#x08f6c;&#x079fb;&#x05e72;&#x09884;&#x03002;&#x06211;&#x04eec;&#x07684;&#x04e3b;&#x08981;&#x06210;&#x0679c;&#x0662f;&#x079ef;&#x06781;&#x07684;&#x04e34;&#x05e8a;&#x07597;&#x06548;&#x0ff0c;&#x056e0;&#x06b64;&#x0800c;&#x088ab;&#x05b9a;&#x04e49;&#x04e3a;&#x06cbb;&#x07597;&#x06210;&#x0529f;&#x03001;&#x06cbb;&#x07597;&#x05b8c;&#x06210;&#x06216;&#x05fae;&#x0751f;&#x07269;&#x05b66;&#x06cbb;&#x07597;&#x03002;&#x0901a;&#x08fc7;&#x04f7f;&#x07528;&#x08d2d;&#x04e70;&#x0529b;&#x05e73;&#x04ef7;&#x06362;&#x07b97;&#x0ff0c;&#x06211;&#x04eec;&#x05c06;&#x06bcf;&#x09879;&#x07814;&#x07a76;&#x04e2d;&#x06bcf;&#x0540d;&#x060a3;&#x08005;&#x063a5;&#x06536;&#x07684;&#x073b0;&#x091d1;&#x06570;&#x0989d;&#x06362;&#x07b97;&#x06210;&#x056fd;&#x09645;&#x07f8e;&#x05143;&#x000a0;(Int$)&#x03002;&#x06211;&#x04eec;&#x091c7;&#x07528;&#x0968f;&#x0673a;&#x06548;&#x05e94;&#x0835f;&#x08403;&#x05206;&#x06790;&#x06cd5;&#x04e3a;&#x04e3b;&#x08981;&#x07ed3;&#x0679c;&#x08ba1;&#x07b97;&#x04e86;&#x04f18;&#x052bf;&#x06bd4;&#x03002;</p></sec><sec><title>&#x07ed3;&#x0679c;</title><p>&#x05176;&#x04e2d;&#x0ff0c;&#x06709;&#x0516b;&#x09879;&#x07814;&#x07a76;&#x07b26;&#x05408;&#x07eb3;&#x05165;&#x05ba1;&#x067e5;&#x07684;&#x08d44;&#x0683c;&#x06807;&#x051c6;&#x03002;&#x06709;&#x04e03;&#x09879;&#x07814;&#x07a76;&#x08bc4;&#x04f30;&#x04e86;&#x07ed3;&#x06838;&#x075c5;&#x04e13;&#x09879;&#x05e72;&#x09884;&#x0ff0c;&#x05176;&#x05e73;&#x05747;&#x073b0;&#x091d1;&#x06570;&#x0989d;&#x04ece;&#x000a0;193&#x000a0;&#x081f3;&#x000a0;858&#x000a0;&#x056fd;&#x09645;&#x07f8e;&#x05143;&#x04e0d;&#x07b49;&#x03002;&#x06709;&#x04e00;&#x09879;&#x07814;&#x07a76;&#x08bc4;&#x04f30;&#x04e86;&#x07ed3;&#x06838;&#x075c5;&#x0654f;&#x0611f;&#x05e72;&#x09884;&#x0ff0c;&#x05176;&#x05e73;&#x05747;&#x073b0;&#x091d1;&#x06570;&#x0989d;&#x04e3a;&#x000a0;101&#x000a0;&#x056fd;&#x09645;&#x07f8e;&#x05143;&#x03002;&#x06709;&#x056db;&#x09879;&#x07814;&#x07a76;&#x05305;&#x0542b;&#x0975e;&#x073b0;&#x091d1;&#x05171;&#x0540c;&#x05e72;&#x09884;&#x03002;&#x06240;&#x06709;&#x07814;&#x07a76;&#x05747;&#x08868;&#x0660e;&#x05e72;&#x09884;&#x07ec4;&#x07684;&#x04e3b;&#x08981;&#x07ed3;&#x0679c;&#x04f18;&#x04e8e;&#x05bf9;&#x07167;&#x07ec4;&#x03002;&#x0901a;&#x08fc7;&#x06392;&#x09664;&#x04e09;&#x09879;&#x05177;&#x06709;&#x09ad8;&#x05ea6;&#x0504f;&#x089c1;&#x098ce;&#x09669;&#x07684;&#x07814;&#x07a76;&#x0ff0c;&#x063a5;&#x06536;&#x07ed3;&#x06838;&#x075c5;&#x04e13;&#x09879;&#x073b0;&#x091d1;&#x08f6c;&#x079fb;&#x07684;&#x060a3;&#x08005;&#x06bd4;&#x063a7;&#x05236;&#x07ec4;&#x04e2d;&#x07684;&#x060a3;&#x08005;&#x066f4;&#x053ef;&#x080fd;&#x051fa;&#x073b0;&#x079ef;&#x06781;&#x07684;&#x04e34;&#x05e8a;&#x07597;&#x06548;&#x0ff08;&#x06216;&#x0ff1a;1.77&#x0ff1b;95%&#x000a0;&#x07f6e;&#x04fe1;&#x0533a;&#x095f4;&#x0ff1a;1.57&#x02013;2.01)&#x03002;</p></sec><sec><title>&#x07ed3;&#x08bba;</title><p>&#x06709;&#x06548;&#x08bc1;&#x0636e;&#x0663e;&#x0793a;&#x04e2d;&#x04f4e;&#x06536;&#x05165;&#x056fd;&#x05bb6;&#x07684;&#x060a3;&#x08005;&#x05728;&#x06cbb;&#x07597;&#x06d3b;&#x052a8;&#x06027;&#x080ba;&#x07ed3;&#x06838;&#x0671f;&#x095f4;&#x063a5;&#x06536;&#x073b0;&#x091d1;&#x05e72;&#x09884;&#x066f4;&#x06709;&#x053ef;&#x080fd;&#x062e5;&#x06709;&#x079ef;&#x06781;&#x07684;&#x04e34;&#x05e8a;&#x07597;&#x06548;&#x03002;&#x08fd9;&#x04e9b;&#x053d1;&#x073b0;&#x0652f;&#x06301;&#x05c06;&#x07ed3;&#x06838;&#x075c5;&#x06cbb;&#x07597;&#x065b9;&#x06848;&#x04e2d;&#x07684;&#x073b0;&#x091d1;&#x08f6c;&#x079fb;&#x05e72;&#x09884;&#x07eb3;&#x05165;&#x0793e;&#x04f1a;&#x04fdd;&#x0969c;&#x08ba1;&#x05212;&#x04e2d;&#x03002;<bold/></p></sec></trans-abstract><trans-abstract xml:lang="ru"><title>&#x00420;&#x00435;&#x00437;&#x0044e;&#x0043c;&#x00435;</title><sec><title>&#x00426;&#x00435;&#x0043b;&#x0044c;</title><p>&#x0041e;&#x00446;&#x00435;&#x0043d;&#x00438;&#x00442;&#x0044c; &#x00432;&#x0043b;&#x00438;&#x0044f;&#x0043d;&#x00438;&#x00435; &#x00444;&#x00438;&#x0043d;&#x00430;&#x0043d;&#x00441;&#x0043e;&#x00432;&#x0043e;&#x00439; &#x0043f;&#x0043e;&#x0043c;&#x0043e;&#x00449;&#x00438; &#x0043d;&#x00430; &#x00443;&#x0043b;&#x00443;&#x00447;&#x00448;&#x00435;&#x0043d;&#x00438;&#x00435; &#x00440;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x0043e;&#x00432; &#x0043b;&#x00435;&#x00447;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00430;&#x0043a;&#x00442;&#x00438;&#x00432;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x00442;&#x00443;&#x00431;&#x00435;&#x00440;&#x0043a;&#x00443;&#x0043b;&#x00435;&#x00437;&#x00430; &#x0043b;&#x00435;&#x00433;&#x0043a;&#x00438;&#x00445; &#x00432; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00430;&#x00445; &#x00441; &#x0043d;&#x00438;&#x00437;&#x0043a;&#x00438;&#x0043c; &#x00438; &#x00441;&#x00440;&#x00435;&#x00434;&#x0043d;&#x00438;&#x0043c; &#x00443;&#x00440;&#x0043e;&#x00432;&#x0043d;&#x00435;&#x0043c; &#x00434;&#x0043e;&#x00445;&#x0043e;&#x00434;&#x00430;.</p></sec><sec><title>&#x0041c;&#x00435;&#x00442;&#x0043e;&#x00434;&#x0044b;</title><p>&#x00410;&#x00432;&#x00442;&#x0043e;&#x00440;&#x0044b; &#x0043f;&#x00440;&#x0043e;&#x00432;&#x00435;&#x0043b;&#x00438; &#x0043f;&#x0043e;&#x00438;&#x00441;&#x0043a; &#x00432; &#x00431;&#x00430;&#x00437;&#x00430;&#x00445; &#x00434;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445; PubMed&#x000ae;, Embase&#x000ae;, &#x0041a;&#x0043e;&#x00445;&#x00440;&#x00430;&#x0043d;&#x0043e;&#x00432;&#x00441;&#x0043a;&#x0043e;&#x00439; &#x00431;&#x00438;&#x00431;&#x0043b;&#x00438;&#x0043e;&#x00442;&#x00435;&#x0043a;&#x00435;&#x000a0;(Cochrane Library) &#x00438; &#x00432; &#x00440;&#x00435;&#x00435;&#x00441;&#x00442;&#x00440;&#x00435; ClinicalTrials.gov &#x0043d;&#x00430; &#x0043f;&#x00440;&#x00435;&#x00434;&#x0043c;&#x00435;&#x00442; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439;, &#x0043e;&#x0043f;&#x00443;&#x00431;&#x0043b;&#x00438;&#x0043a;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00434;&#x0043e; 4&#x000a0;&#x00430;&#x00432;&#x00433;&#x00443;&#x00441;&#x00442;&#x00430; 2017&#x000a0;&#x00433;&#x0043e;&#x00434;&#x00430;, &#x00432; &#x0043a;&#x0043e;&#x00442;&#x0043e;&#x00440;&#x0044b;&#x00445; &#x00441;&#x0043e;&#x0043e;&#x00431;&#x00449;&#x00430;&#x0043b;&#x0043e;&#x00441;&#x0044c; &#x0043e;&#x00431; &#x0043e;&#x0043a;&#x00430;&#x00437;&#x00430;&#x0043d;&#x00438;&#x00438; &#x00444;&#x00438;&#x0043d;&#x00430;&#x0043d;&#x00441;&#x0043e;&#x00432;&#x0043e;&#x00439; &#x0043f;&#x0043e;&#x0043c;&#x0043e;&#x00449;&#x00438; &#x00432; &#x00445;&#x0043e;&#x00434;&#x00435; &#x0043b;&#x00435;&#x00447;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00430;&#x0043a;&#x00442;&#x00438;&#x00432;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x00442;&#x00443;&#x00431;&#x00435;&#x00440;&#x0043a;&#x00443;&#x0043b;&#x00435;&#x00437;&#x00430; &#x0043b;&#x00435;&#x00433;&#x0043a;&#x00438;&#x00445; &#x00432; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00430;&#x00445; &#x00441; &#x0043d;&#x00438;&#x00437;&#x0043a;&#x00438;&#x0043c; &#x00438; &#x00441;&#x00440;&#x00435;&#x00434;&#x0043d;&#x00438;&#x0043c; &#x00443;&#x00440;&#x0043e;&#x00432;&#x0043d;&#x00435;&#x0043c; &#x00434;&#x0043e;&#x00445;&#x0043e;&#x00434;&#x00430;. &#x00412; &#x0043a;&#x00430;&#x00447;&#x00435;&#x00441;&#x00442;&#x00432;&#x00435; &#x0043e;&#x00441;&#x0043d;&#x0043e;&#x00432;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x00440;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x00430; &#x00440;&#x00430;&#x00441;&#x00441;&#x0043c;&#x00430;&#x00442;&#x00440;&#x00438;&#x00432;&#x00430;&#x0043b;&#x00441;&#x0044f; &#x0043f;&#x0043e;&#x0043b;&#x0043e;&#x00436;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00439; &#x0043a;&#x0043b;&#x00438;&#x0043d;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438;&#x00439; &#x00438;&#x00441;&#x00445;&#x0043e;&#x00434;, &#x0043e;&#x0043f;&#x00440;&#x00435;&#x00434;&#x00435;&#x0043b;&#x0044f;&#x00435;&#x0043c;&#x0044b;&#x00439; &#x0043a;&#x00430;&#x0043a; &#x0044d;&#x00444;&#x00444;&#x00435;&#x0043a;&#x00442;&#x00438;&#x00432;&#x0043d;&#x0043e;&#x00435; &#x0043b;&#x00435;&#x00447;&#x00435;&#x0043d;&#x00438;&#x00435;, &#x00437;&#x00430;&#x00432;&#x00435;&#x00440;&#x00448;&#x00435;&#x0043d;&#x00438;&#x00435; &#x0043b;&#x00435;&#x00447;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00438;&#x0043b;&#x00438; &#x0043c;&#x00438;&#x0043a;&#x00440;&#x0043e;&#x00431;&#x00438;&#x0043e;&#x0043b;&#x0043e;&#x00433;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x0043e;&#x00435; &#x00438;&#x00437;&#x0043b;&#x00435;&#x00447;&#x00435;&#x0043d;&#x00438;&#x00435;. &#x00418;&#x00441;&#x0043f;&#x0043e;&#x0043b;&#x0044c;&#x00437;&#x00443;&#x0044f; &#x0043a;&#x0043e;&#x0044d;&#x00444;&#x00444;&#x00438;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442; &#x0043f;&#x00435;&#x00440;&#x00435;&#x00441;&#x00447;&#x00435;&#x00442;&#x00430; &#x0043f;&#x00430;&#x00440;&#x00438;&#x00442;&#x00435;&#x00442;&#x00430; &#x0043f;&#x0043e;&#x0043a;&#x00443;&#x0043f;&#x00430;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00439; &#x00441;&#x0043f;&#x0043e;&#x00441;&#x0043e;&#x00431;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438;, &#x00430;&#x00432;&#x00442;&#x0043e;&#x00440;&#x0044b; &#x0043f;&#x00435;&#x00440;&#x00435;&#x00432;&#x00435;&#x0043b;&#x00438; &#x0043a;&#x0043e;&#x0043b;&#x00438;&#x00447;&#x00435;&#x00441;&#x00442;&#x00432;&#x0043e; &#x00434;&#x00435;&#x0043d;&#x00435;&#x00436;&#x0043d;&#x0044b;&#x00445; &#x00441;&#x00440;&#x00435;&#x00434;&#x00441;&#x00442;&#x00432;, &#x0043f;&#x0043e;&#x0043b;&#x00443;&#x00447;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043a;&#x00430;&#x00436;&#x00434;&#x0044b;&#x0043c; &#x0043f;&#x00430;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442;&#x0043e;&#x0043c; &#x00432; &#x00440;&#x00430;&#x0043c;&#x0043a;&#x00430;&#x00445; &#x0043a;&#x00430;&#x00436;&#x00434;&#x0043e;&#x00433;&#x0043e; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f;, &#x00432; &#x0043c;&#x00435;&#x00436;&#x00434;&#x00443;&#x0043d;&#x00430;&#x00440;&#x0043e;&#x00434;&#x0043d;&#x0044b;&#x00435; &#x00434;&#x0043e;&#x0043b;&#x0043b;&#x00430;&#x00440;&#x0044b;. &#x00410;&#x00432;&#x00442;&#x0043e;&#x00440;&#x0044b; &#x00440;&#x00430;&#x00441;&#x00441;&#x00447;&#x00438;&#x00442;&#x00430;&#x0043b;&#x00438; &#x0043e;&#x00442;&#x0043d;&#x0043e;&#x00448;&#x00435;&#x0043d;&#x00438;&#x00435; &#x00448;&#x00430;&#x0043d;&#x00441;&#x0043e;&#x00432;&#x000a0;(&#x0041e;&#x00428;) &#x00434;&#x0043b;&#x0044f; &#x0043e;&#x00441;&#x0043d;&#x0043e;&#x00432;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x00440;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x00430;, &#x00438;&#x00441;&#x0043f;&#x0043e;&#x0043b;&#x0044c;&#x00437;&#x00443;&#x0044f; &#x0043c;&#x00435;&#x00442;&#x00430;&#x00430;&#x0043d;&#x00430;&#x0043b;&#x00438;&#x00437; &#x00441;&#x0043b;&#x00443;&#x00447;&#x00430;&#x00439;&#x0043d;&#x0044b;&#x00445; &#x0044d;&#x00444;&#x00444;&#x00435;&#x0043a;&#x00442;&#x0043e;&#x00432;.</p></sec><sec><title>&#x00420;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x0044b;</title><p>&#x00412;&#x0043e;&#x00441;&#x00435;&#x0043c;&#x0044c; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439; &#x00441;&#x0043e;&#x0043e;&#x00442;&#x00432;&#x00435;&#x00442;&#x00441;&#x00442;&#x00432;&#x0043e;&#x00432;&#x00430;&#x0043b;&#x00438; &#x0043a;&#x00440;&#x00438;&#x00442;&#x00435;&#x00440;&#x00438;&#x0044f;&#x0043c; &#x0043f;&#x00440;&#x00438;&#x00435;&#x0043c;&#x0043b;&#x00435;&#x0043c;&#x0043e;&#x00441;&#x00442;&#x00438; &#x00434;&#x0043b;&#x0044f; &#x00432;&#x0043a;&#x0043b;&#x0044e;&#x00447;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00432; &#x0043e;&#x00431;&#x00437;&#x0043e;&#x00440;. &#x00412; &#x00441;&#x00435;&#x0043c;&#x00438; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f;&#x00445; &#x0043e;&#x00446;&#x00435;&#x0043d;&#x00438;&#x00432;&#x00430;&#x0043b;&#x00430;&#x00441;&#x0044c; &#x00444;&#x00438;&#x0043d;&#x00430;&#x0043d;&#x00441;&#x0043e;&#x00432;&#x00430;&#x0044f; &#x0043f;&#x0043e;&#x0043c;&#x0043e;&#x00449;&#x0044c;, &#x00441;&#x00432;&#x0044f;&#x00437;&#x00430;&#x0043d;&#x0043d;&#x00430;&#x0044f; &#x00441; &#x0043b;&#x00435;&#x00447;&#x00435;&#x0043d;&#x00438;&#x00435;&#x0043c; &#x00442;&#x00443;&#x00431;&#x00435;&#x00440;&#x0043a;&#x00443;&#x0043b;&#x00435;&#x00437;&#x00430;, &#x00441;&#x0043e; &#x00441;&#x00440;&#x00435;&#x00434;&#x0043d;&#x00438;&#x0043c; &#x0043a;&#x0043e;&#x0043b;&#x00438;&#x00447;&#x00435;&#x00441;&#x00442;&#x00432;&#x0043e;&#x0043c; &#x00434;&#x00435;&#x0043d;&#x00435;&#x00436;&#x0043d;&#x0044b;&#x00445; &#x00441;&#x00440;&#x00435;&#x00434;&#x00441;&#x00442;&#x00432; &#x00432; &#x00434;&#x00438;&#x00430;&#x0043f;&#x00430;&#x00437;&#x0043e;&#x0043d;&#x00435; &#x0043e;&#x00442; 193 &#x00434;&#x0043e; 858&#x000a0;&#x0043c;&#x00435;&#x00436;&#x00434;&#x00443;&#x0043d;&#x00430;&#x00440;&#x0043e;&#x00434;&#x0043d;&#x0044b;&#x00445; &#x00434;&#x0043e;&#x0043b;&#x0043b;&#x00430;&#x00440;&#x0043e;&#x00432;. &#x00412; &#x0043e;&#x00434;&#x0043d;&#x0043e;&#x0043c; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00438; &#x0043e;&#x00446;&#x00435;&#x0043d;&#x00438;&#x00432;&#x00430;&#x0043b;&#x00430;&#x00441;&#x0044c; &#x00444;&#x00438;&#x0043d;&#x00430;&#x0043d;&#x00441;&#x0043e;&#x00432;&#x00430;&#x0044f; &#x0043f;&#x0043e;&#x0043c;&#x0043e;&#x00449;&#x0044c;, &#x00441;&#x00432;&#x0044f;&#x00437;&#x00430;&#x0043d;&#x0043d;&#x00430;&#x0044f; &#x00441; &#x0043b;&#x00435;&#x00447;&#x00435;&#x0043d;&#x00438;&#x00435;&#x0043c; &#x00442;&#x00443;&#x00431;&#x00435;&#x00440;&#x0043a;&#x00443;&#x0043b;&#x00435;&#x00437;&#x00430;, &#x00441;&#x0043e; &#x00441;&#x00440;&#x00435;&#x00434;&#x0043d;&#x00438;&#x0043c; &#x0043a;&#x0043e;&#x0043b;&#x00438;&#x00447;&#x00435;&#x00441;&#x00442;&#x00432;&#x0043e;&#x0043c; &#x00434;&#x00435;&#x0043d;&#x00435;&#x00436;&#x0043d;&#x0044b;&#x00445; &#x00441;&#x00440;&#x00435;&#x00434;&#x00441;&#x00442;&#x00432;, &#x00440;&#x00430;&#x00432;&#x0043d;&#x0044b;&#x0043c; 101&#x000a0;&#x0043c;&#x00435;&#x00436;&#x00434;&#x00443;&#x0043d;&#x00430;&#x00440;&#x0043e;&#x00434;&#x0043d;&#x0043e;&#x0043c;&#x00443; &#x00434;&#x0043e;&#x0043b;&#x0043b;&#x00430;&#x00440;&#x00443;. &#x00427;&#x00435;&#x00442;&#x0044b;&#x00440;&#x00435; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f; &#x00432;&#x0043a;&#x0043b;&#x0044e;&#x00447;&#x00430;&#x0043b;&#x00438; &#x0043d;&#x00435;&#x00434;&#x00435;&#x0043d;&#x00435;&#x00436;&#x0043d;&#x0044b;&#x00435; &#x00441;&#x0043e;&#x00432;&#x0043c;&#x00435;&#x00441;&#x00442;&#x0043d;&#x0044b;&#x00435; &#x00432;&#x0043c;&#x00435;&#x00448;&#x00430;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x00441;&#x00442;&#x00432;&#x00430;. &#x00412;&#x0043e; &#x00432;&#x00441;&#x00435;&#x00445; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f;&#x00445; &#x00434;&#x0043b;&#x0044f; &#x00433;&#x00440;&#x00443;&#x0043f;&#x0043f;&#x0044b; &#x00432;&#x0043c;&#x00435;&#x00448;&#x00430;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x00441;&#x00442;&#x00432;&#x00430; &#x0043d;&#x00430;&#x00431;&#x0043b;&#x0044e;&#x00434;&#x00430;&#x0043b;&#x00441;&#x0044f; &#x0043b;&#x00443;&#x00447;&#x00448;&#x00438;&#x00439; &#x0043e;&#x00441;&#x0043d;&#x0043e;&#x00432;&#x0043d;&#x0043e;&#x00439; &#x00440;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442; &#x0043f;&#x0043e; &#x00441;&#x00440;&#x00430;&#x00432;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044e; &#x00441; &#x0043a;&#x0043e;&#x0043d;&#x00442;&#x00440;&#x0043e;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00439; &#x00433;&#x00440;&#x00443;&#x0043f;&#x0043f;&#x0043e;&#x00439;. &#x0041f;&#x0043e;&#x00441;&#x0043b;&#x00435; &#x00438;&#x00441;&#x0043a;&#x0043b;&#x0044e;&#x00447;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00442;&#x00440;&#x00435;&#x00445; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439; &#x00441; &#x00432;&#x0044b;&#x00441;&#x0043e;&#x0043a;&#x00438;&#x0043c; &#x00440;&#x00438;&#x00441;&#x0043a;&#x0043e;&#x0043c; &#x00441;&#x00438;&#x00441;&#x00442;&#x00435;&#x0043c;&#x00430;&#x00442;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x0043e;&#x00439; &#x0043e;&#x00448;&#x00438;&#x00431;&#x0043a;&#x00438; &#x00431;&#x0044b;&#x0043b;&#x0043e; &#x0043e;&#x00431;&#x0043d;&#x00430;&#x00440;&#x00443;&#x00436;&#x00435;&#x0043d;&#x0043e;, &#x00447;&#x00442;&#x0043e; &#x00443; &#x0043f;&#x00430;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442;&#x0043e;&#x00432;, &#x0043f;&#x0043e;&#x0043b;&#x00443;&#x00447;&#x00430;&#x0044e;&#x00449;&#x00438;&#x00445; &#x00444;&#x00438;&#x0043d;&#x00430;&#x0043d;&#x00441;&#x0043e;&#x00432;&#x00443;&#x0044e; &#x0043f;&#x0043e;&#x0043c;&#x0043e;&#x00449;&#x0044c;, &#x00441;&#x00432;&#x0044f;&#x00437;&#x00430;&#x0043d;&#x0043d;&#x00443;&#x0044e; &#x00441; &#x0043b;&#x00435;&#x00447;&#x00435;&#x0043d;&#x00438;&#x00435;&#x0043c; &#x00442;&#x00443;&#x00431;&#x00435;&#x00440;&#x0043a;&#x00443;&#x0043b;&#x00435;&#x00437;&#x00430;, &#x00447;&#x00430;&#x00449;&#x00435; &#x0043d;&#x00430;&#x00431;&#x0043b;&#x0044e;&#x00434;&#x00430;&#x0043b;&#x00441;&#x0044f; &#x0043f;&#x0043e;&#x0043b;&#x0043e;&#x00436;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00439; &#x0043a;&#x0043b;&#x00438;&#x0043d;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438;&#x00439; &#x00438;&#x00441;&#x00445;&#x0043e;&#x00434;, &#x00447;&#x00435;&#x0043c; &#x00443; &#x0043f;&#x00430;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442;&#x0043e;&#x00432; &#x00432; &#x0043a;&#x0043e;&#x0043d;&#x00442;&#x00440;&#x0043e;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00445; &#x00433;&#x00440;&#x00443;&#x0043f;&#x0043f;&#x00430;&#x00445;&#x000a0;(&#x0041e;&#x00428;: 1,77; 95%-&#x00439; &#x00414;&#x00418;: 1,57&#x02013;2,01).</p></sec><sec><title>&#x00412;&#x0044b;&#x00432;&#x0043e;&#x00434;</title><p>&#x00418;&#x0043c;&#x00435;&#x0044e;&#x00449;&#x00438;&#x00435;&#x00441;&#x0044f; &#x00434;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x00441;&#x00432;&#x00438;&#x00434;&#x00435;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x00441;&#x00442;&#x00432;&#x00443;&#x0044e;&#x00442; &#x0043e; &#x00442;&#x0043e;&#x0043c;, &#x00447;&#x00442;&#x0043e; &#x00443; &#x0043f;&#x00430;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442;&#x0043e;&#x00432; &#x00432; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00430;&#x00445; &#x00441; &#x0043d;&#x00438;&#x00437;&#x0043a;&#x00438;&#x0043c; &#x00438; &#x00441;&#x00440;&#x00435;&#x00434;&#x0043d;&#x00438;&#x0043c; &#x00443;&#x00440;&#x0043e;&#x00432;&#x0043d;&#x00435;&#x0043c; &#x00434;&#x0043e;&#x00445;&#x0043e;&#x00434;&#x00430;, &#x0043f;&#x0043e;&#x0043b;&#x00443;&#x00447;&#x00430;&#x0044e;&#x00449;&#x00438;&#x00445; &#x00444;&#x00438;&#x0043d;&#x00430;&#x0043d;&#x00441;&#x0043e;&#x00432;&#x00443;&#x0044e; &#x0043f;&#x0043e;&#x0043c;&#x0043e;&#x00449;&#x0044c; &#x00432;&#x0043e; &#x00432;&#x00440;&#x00435;&#x0043c;&#x0044f; &#x0043b;&#x00435;&#x00447;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00430;&#x0043a;&#x00442;&#x00438;&#x00432;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x00442;&#x00443;&#x00431;&#x00435;&#x00440;&#x0043a;&#x00443;&#x0043b;&#x00435;&#x00437;&#x00430; &#x0043b;&#x00435;&#x00433;&#x0043a;&#x00438;&#x00445;, &#x00447;&#x00430;&#x00449;&#x00435; &#x0043d;&#x00430;&#x00431;&#x0043b;&#x0044e;&#x00434;&#x00430;&#x00435;&#x00442;&#x00441;&#x0044f; &#x0043f;&#x0043e;&#x0043b;&#x0043e;&#x00436;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00439; &#x0043a;&#x0043b;&#x00438;&#x0043d;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438;&#x00439; &#x00438;&#x00441;&#x00445;&#x0043e;&#x00434;. &#x0042d;&#x00442;&#x00438; &#x00440;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x0044b; &#x0043f;&#x0043e;&#x00434;&#x00442;&#x00432;&#x00435;&#x00440;&#x00436;&#x00434;&#x00430;&#x0044e;&#x00442; &#x00440;&#x00430;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x0044c; &#x00432;&#x0043a;&#x0043b;&#x0044e;&#x00447;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00444;&#x00438;&#x0043d;&#x00430;&#x0043d;&#x00441;&#x0043e;&#x00432;&#x0043e;&#x00439; &#x0043f;&#x0043e;&#x0043c;&#x0043e;&#x00449;&#x00438; &#x00432; &#x00441;&#x00445;&#x00435;&#x0043c;&#x0044b; &#x00441;&#x0043e;&#x00446;&#x00438;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00439; &#x00437;&#x00430;&#x00449;&#x00438;&#x00442;&#x0044b; &#x00432; &#x00440;&#x00430;&#x0043c;&#x0043a;&#x00430;&#x00445; &#x0043f;&#x00440;&#x0043e;&#x00433;&#x00440;&#x00430;&#x0043c;&#x0043c; &#x0043b;&#x00435;&#x00447;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00442;&#x00443;&#x00431;&#x00435;&#x00440;&#x0043a;&#x00443;&#x0043b;&#x00435;&#x00437;&#x00430;.</p></sec></trans-abstract></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Tuberculosis remains one of the top 10 causes of death worldwide, with the highest burden of disease in low- and middle-income countries.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> In these countries, the disease disproportionately affects the most vulnerable populations.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="R2" ref-type="bibr"><sup>2</sup></xref></p><p>In 2015, the World Health Organization&#x02019;s (WHO&#x02019;s) End TB Strategy set the goal of a 90% reduction in tuberculosis deaths, an 80% reduction in tuberculosis incidence rate and zero catastrophic costs for tuberculosis-affected families by 2030.<xref rid="R3" ref-type="bibr"><sup>3</sup></xref> These goals explicitly acknowledge the need to both directly treat people infected with the disease and address social determinants of health to improve tuberculosis outcomes.</p><p>Social protection policies protect individuals or households during periods when they are unable to financially support themselves because of a range of conditions, such as illness or disability.<xref rid="R4" ref-type="bibr"><sup>4</sup></xref> Cash transfer interventions, defined as cash payments provided to selected beneficiaries by formal institutions, are one form of social protection that has been proposed in the setting of tuberculosis.<xref rid="R5" ref-type="bibr"><sup>5</sup></xref><sup>,</sup><xref rid="R6" ref-type="bibr"><sup>6</sup></xref> Such interventions can either be tuberculosis-specific or tuberculosis-sensitive.<xref rid="R6" ref-type="bibr"><sup>6</sup></xref> Tuberculosis-specific interventions target directly tuberculosis patients and their households, and are typically incorporated into existing tuberculosis treatment programmes.<xref rid="R6" ref-type="bibr"><sup>6</sup></xref> A tuberculosis-sensitive intervention is part of a broader social protection scheme, potentially affecting tuberculosis outcomes by targeting communities and groups that are at high risk for tuberculosis. The effect on health outcomes, cost&#x02013;effectiveness and feasibility of these two strategies are not well established and likely to vary based on the local social protection and health-care infrastructure.</p><p>Since a review in 2011 on the effects of cash transfer interventions on tuberculosis outcomes in low- and middle-income countries was inconclusive,<xref rid="R7" ref-type="bibr"><sup>7</sup></xref> we assessed the current state of the evidence for such interventions. We were especially interested if cash transfer to people receiving treatment for active pulmonary tuberculosis affects their clinical outcomes.</p></sec><sec sec-type="methods"><title>Methods</title><p>We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.<xref rid="R8" ref-type="bibr"><sup>8</sup></xref> The review protocol is available from the corresponding author.</p><p>To identify studies on the use of cash transfer interventions during the treatment of active pulmonary tuberculosis in low- and middle-income countries, we searched the online databases PubMed&#x000ae;, Embase&#x000ae;, Cochrane Library and ClinicalTrials.gov. We used the search string &#x0201c;Tuberculosis&#x0201d; AND (&#x0201c;financial support&#x0201d; OR &#x0201c;token economy&#x0201d; OR &#x0201c;reimbursement&#x0201d; OR &#x0201c;economic burden&#x0201d; OR &#x0201c;incentives&#x0201d; OR &#x0201c;cash transfer&#x0201d; OR &#x0201c;enablers&#x0201d;) to identify studies published between the databases&#x02019; inceptions and 4 August 2017. We also manually reviewed reference lists of identified systematic reviews, relevant articles and abstracts from the Union World Conference on Lung Health 2011&#x02013;2016.</p><sec><title>Eligibility criteria</title><p>We considered clinical trials and observational studies published in English, Spanish or French that assessed cash transfer interventions directed at people initiating treatment for microbiologically confirmed or clinically suspected active pulmonary tuberculosis. We used the WHO definition for tuberculosis and the 2017 World Bank&#x02019;s classification of low- and middle-income countries.<xref rid="R9" ref-type="bibr"><sup>9</sup></xref><sup>,</sup><xref rid="R10" ref-type="bibr"><sup>10</sup></xref> We included studies that reported standard outcomes of treatment completion, microbiologic cure or treatment success, which includes both treatment completion and cure.<xref rid="R10" ref-type="bibr"><sup>10</sup></xref></p></sec><sec><title>Study selection and data collection</title><p>After removing duplicate records, two reviewers independently screened titles and abstracts of all records for inclusion in full-text review. After screening, two different reviewers independently applied eligibility criteria to each full-text article. Two reviewers then proceeded to data extraction using a standardized form created for the study (<xref ref-type="boxed-text" rid="B1">Box&#x000a0;1</xref>). Disagreements were settled by consensus among all authors.</p><boxed-text id="B1" position="float" orientation="portrait"><label>Box&#x000a0;1</label><caption><title>Type of data extracted from identified studies on cash interventions to improve tuberculosis outcome</title></caption><p>We extracted data on location; urban and rural setting; time frame; study design; number of subjects; age and gender of participants; HIV prevalence; number with microbiologically confirmed tuberculosis; number with confirmed or suspected MDR and XDR tuberculosis; type of usual care for tuberculosis; annual individual or household income; whether the intervention was conditional; tuberculosis-specific or sensitive intervention; concurrently implemented co-interventions; primary and secondary outcomes.</p><fn-group><fn><p>HIV: human immunodeficiency virus; MDR: multidrug resistant; XRT: extensively-drug resistant.</p></fn></fn-group></boxed-text><p>To better understand the relative amount of cash distributed in the included studies, we converted the average and maximum possible amount of cash received per patient within each study into international dollars (Int$) using the purchasing power parity conversion factor, and then adjusted for inflation into 2016 Int$ with the local inflation conversion factor.<xref rid="R11" ref-type="bibr"><sup>11</sup></xref> If the average amount of cash received by patients in the intervention group was not reported in the article, we contacted the authors to provide the figures.</p><p>Because tuberculosis disproportionately affects the poorest households within a given context,<xref rid="R12" ref-type="bibr"><sup>12</sup></xref> we estimated the average amount of cash received per patient as a proportion of annual individual income by dividing the average amount of cash received per patient by the median income per capita of the lowest quintile of that country from the time period of the study.<xref rid="R11" ref-type="bibr"><sup>11</sup></xref> Household-level income data were not available to estimate the interventions as proportion of annual household income.</p></sec><sec><title>Assessment of bias</title><p>For the randomized study, we assessed risk of bias using the Cochrane Collaboration Risk of Bias Tool, and defined a randomized study as overall high risk of bias if the trial met criteria for high risk of bias in more than one assessed domain.<xref rid="R13" ref-type="bibr"><sup>13</sup></xref> We assessed risk of bias within non-randomized studies using the Newcastle-Ottawa Scale, defining a non-randomized study as overall high risk of bias if it had zero stars in any of the three assessed categories.<xref rid="R14" ref-type="bibr"><sup>14</sup></xref> We generated a funnel plot to evaluate publication bias for studies included in the meta-analysis.</p></sec><sec><title>Data analysis</title><p>All identified studies were included in a qualitative synthesis. After excluding studies at overall high risk of bias, we generated summary effect measures using a random effects model for our primary outcome of interest, the odds ratio (OR) of a positive clinical outcome, defined as either a treatment success; treatment completion, if a study did not report treatment success; or microbiologic cure, if a study did not report treatment success or treatment completion. If a study reported ORs adjusted for potential confounders we included these ratios in our analysis. We assessed heterogeneity by using the Cochran&#x02019;s <italic>Q</italic>&#x000a0;test and the <italic>I<sup>2</sup></italic> statistic.</p><p>Among studies included in meta-analysis, we wanted to investigate sources of heterogeneity, including average amount of cash transfer, presence of non-cash co-intervention, treatment success rate in the control group, urban or rural setting, human immunodeficiency (HIV) prevalence, multidrug resistance (MDR) or extensive-drug resistance (XDR) tuberculosis prevalence and World Bank income classification. However, there was not enough information available to complete a random effects meta-regression model using any of these variables.</p><p>We used Comprehensive Meta-Analysis software version 3 (Biostat, Inc., Englewood, United States of America) and Review Manager Version 5.3 (The Cochrane Collaboration, London, United Kingdom of Great Britain and Northern Ireland) for data analysis.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Study selection</title><p>We identified 1537 publications and after removal of 639 duplicates, we screened 898 titles and abstracts yielding 100 full-text articles to be assessed for eligibility. Of these full-text articles, 92 were excluded (<xref ref-type="fig" rid="F1">Fig.&#x000a0;1</xref>). We included eight eligible articles: one randomized control trial,<xref rid="R15" ref-type="bibr"><sup>15</sup></xref> two non-randomized intervention studies,<xref rid="R16" ref-type="bibr"><sup>16</sup></xref><sup>,</sup><xref rid="R17" ref-type="bibr"><sup>17</sup></xref> and five observational studies,<xref rid="R18" ref-type="bibr"><sup>18</sup></xref><sup>&#x02013;</sup><xref rid="R22" ref-type="bibr"><sup>22</sup></xref> comprising a total of 21&#x02009;976 subjects.</p><fig id="F1" fig-type="figure" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Flowchart showing the selection of studies on cash interventions to improve tuberculosis clinical outcomes, 1991&#x02013;2017</p></caption><graphic xlink:href="BLT.18.208959-F1"/></fig></sec><sec><title>Study settings and populations</title><p><xref rid="T1" ref-type="table">Table&#x000a0;1</xref> summarizes the settings and populations of the included studies. With the exception of one study that took place in 1989&#x02013;1990,<xref rid="R17" ref-type="bibr"><sup>17</sup></xref> the studies assessed cash transfer interventions between 2004 and 2015. The settings varied: one study took place in a rural clinic,<xref rid="R17" ref-type="bibr"><sup>17</sup></xref> one in a large rural secondary-care facility,<xref rid="R16" ref-type="bibr"><sup>16</sup></xref> four in urban centres,<xref rid="R15" ref-type="bibr"><sup>15</sup></xref><sup>,</sup><xref rid="R19" ref-type="bibr"><sup>19</sup></xref><sup>&#x02013;</sup><xref rid="R21" ref-type="bibr"><sup>21</sup></xref> and two were nation-wide studies.<xref rid="R18" ref-type="bibr"><sup>18</sup></xref><sup>,</sup><xref rid="R22" ref-type="bibr"><sup>22</sup></xref> Three of the studies took place in countries currently on the WHO list of high-burden countries for tuberculosis<xref rid="R16" ref-type="bibr"><sup>16</sup></xref><sup>,</sup><xref rid="R19" ref-type="bibr"><sup>19</sup></xref><sup>,</sup><xref rid="R22" ref-type="bibr"><sup>22</sup></xref><sup>,</sup><xref rid="R23" ref-type="bibr"><sup>23</sup></xref> and two other studies were in a country currently considered high burden for MDR tuberculosis.<xref rid="R15" ref-type="bibr"><sup>15</sup></xref><sup>,</sup><xref rid="R21" ref-type="bibr"><sup>21</sup></xref></p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Design, setting and population of included studies in the systematic review on cash interventions to improve tuberculosis clinical outcomes, 1991&#x02013;2017</title></caption><table frame="hsides" rules="groups"><col width="51" span="1"/><col width="42" span="1"/><col width="77" span="1"/><col width="70" span="1"/><col width="42" span="1"/><col width="63" span="1"/><col width="35" span="1"/><col width="42" span="1"/><col width="92" span="1"/><col width="99" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Author, publication year</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Year of study</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Study design and setting</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Usual care</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">% male</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">% smear positive</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">% HIV</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">% MDR tuberculosis</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Intervention group</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Control group</th></tr></thead><tbody><tr><td colspan="10" valign="top" align="left" scope="col" rowspan="1"><bold>Tuberculosis-specific interventions</bold></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Farmer et al.,<xref rid="R17" ref-type="bibr"><sup>17</sup></xref> 1991</td><td valign="top" align="center" rowspan="1" colspan="1">1989&#x02013;1990</td><td valign="top" align="left" rowspan="1" colspan="1">Cluster non-randomized intervention study in a clinic in rural Haiti </td><td valign="top" align="left" rowspan="1" colspan="1">Free care, no community health workers or DOTS</td><td valign="top" align="center" rowspan="1" colspan="1">33</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td><td valign="top" align="left" rowspan="1" colspan="1">People with newly diagnosed tuberculosis from sector adjacent to clinic</td><td valign="top" align="left" rowspan="1" colspan="1">People with newly diagnosed tuberculosis from outside sector adjacent to clinic</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Chirico et al.,<xref rid="R20" ref-type="bibr"><sup>20</sup></xref> 2011</td><td valign="top" align="center" rowspan="1" colspan="1">2004&#x02013;2008</td><td valign="top" align="left" rowspan="1" colspan="1">Retrospective cohort in one health district of Buenos Aires, Argentina</td><td valign="top" align="left" rowspan="1" colspan="1">51% of patients receiving DOTS, cost of care NR</td><td valign="top" align="center" rowspan="1" colspan="1">57</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td valign="top" align="center" rowspan="1" colspan="1">0.91</td><td valign="top" align="left" rowspan="1" colspan="1">All people with newly diagnosed tuberculosis reported to national tuberculosis control programme</td><td valign="top" align="left" rowspan="1" colspan="1">People with newly diagnosed tuberculosis who did not get the intervention because deemed not to have the financial need, chosen at random among all people who did not get the intervention</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Rocha et al.,<xref rid="R21" ref-type="bibr"><sup>21</sup></xref> 2011</td><td valign="top" align="center" rowspan="1" colspan="1">2007&#x02013;2010</td><td valign="top" align="left" rowspan="1" colspan="1">Cohort with historical control in eight shantytowns in Lima, Peru</td><td valign="top" align="left" rowspan="1" colspan="1">DOTS, free care</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td><td valign="top" align="left" rowspan="1" colspan="1">People with newly diagnosed tuberculosis from households in the national tuberculosis programme where intervention had been implemented</td><td valign="top" align="left" rowspan="1" colspan="1">People with newly diagnosed tuberculosis from households in the national tuberculosis programme where the intervention had not yet been implemented</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ciobanu et al.,<xref rid="R18" ref-type="bibr"><sup>18</sup></xref> 2014</td><td valign="top" align="center" rowspan="1" colspan="1">2008, 2011</td><td valign="top" align="left" rowspan="1" colspan="1">Nation-wide retrospective cohort with historical control in the Republic of Moldova</td><td valign="top" align="left" rowspan="1" colspan="1">DOTS, cost of care NR</td><td valign="top" align="center" rowspan="1" colspan="1">69</td><td valign="top" align="center" rowspan="1" colspan="1">36</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">Adults with drug-susceptible tuberculosis registered for treatment in 2011 (after introduction of incentives)</td><td valign="top" align="left" rowspan="1" colspan="1">Adults with drug-susceptible tuberculosis registered for treatment in 2008 (before introduction of incentives)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Lu et al.,<xref rid="R19" ref-type="bibr"><sup>19</sup></xref> 2015</td><td valign="top" align="center" rowspan="1" colspan="1">2006&#x02013;2010</td><td valign="top" align="left" rowspan="1" colspan="1">Retrospective cohort in Shanghai, China</td><td valign="top" align="left" rowspan="1" colspan="1">DOTS, free care</td><td valign="top" align="center" rowspan="1" colspan="1">63</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">Migrants treated for smear-positive pulmonary tuberculosis living in one of the eight districts providing cash</td><td valign="top" align="left" rowspan="1" colspan="1">Migrants treated for smear-positive pulmonary tuberculosis living in one of the nine districts not providing cash</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ukwaja et al.,<xref rid="R16" ref-type="bibr"><sup>16</sup></xref> 2017</td><td valign="top" align="center" rowspan="1" colspan="1">2014</td><td valign="top" align="left" rowspan="1" colspan="1">Prospective pre- and post- intervention in a large, rural, secondary-care facility in Ebonyi State, Nigeria</td><td valign="top" align="left" rowspan="1" colspan="1">DOTS, cost of care NR</td><td valign="top" align="center" rowspan="1" colspan="1">54</td><td valign="top" align="center" rowspan="1" colspan="1">55</td><td valign="top" align="center" rowspan="1" colspan="1">15</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">All registered people receiving first-line anti-tuberculosis treatment at study site during 3-month period of intervention</td><td valign="top" align="left" rowspan="1" colspan="1">All registered people receiving first-line anti-tuberculosis treatment at study site during 3-month period without financial package</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Wingfield et al.,<xref rid="R15" ref-type="bibr"><sup>15</sup></xref> 2017</td><td valign="top" align="center" rowspan="1" colspan="1">2014&#x02013;2015</td><td valign="top" align="left" rowspan="1" colspan="1">Cluster randomized control trial in thirty-two contiguous shantytowns in Callao, Peru</td><td valign="top" align="left" rowspan="1" colspan="1">DOTS, free care</td><td valign="top" align="center" rowspan="1" colspan="1">62</td><td valign="top" align="center" rowspan="1" colspan="1">70</td><td valign="top" align="center" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">9</td><td valign="top" align="left" rowspan="1" colspan="1">People starting treatment for tuberculosis administered by the national tuberculosis programme, randomized to receive the socioeconomic support intervention</td><td valign="top" align="left" rowspan="1" colspan="1">People starting treatment for tuberculosis administered by the national tuberculosis programme, randomized not to receive the socioeconomic support intervention</td></tr><tr><td colspan="10" valign="top" align="left" scope="col" rowspan="1"><bold>Tuberculosis-sensitive interventions</bold></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Torrens et al.,<xref rid="R22" ref-type="bibr"><sup>22</sup></xref> 2016</td><td valign="top" align="center" rowspan="1" colspan="1">2010</td><td valign="top" align="left" rowspan="1" colspan="1">Nation-wide retrospective cohort in Brazil</td><td valign="top" align="left" rowspan="1" colspan="1">Free diagnostics and treatment for all patients. Tuberculosis patients only enrolled into directly observed therapy if judged to be able to complete treatment</td><td valign="top" align="center" rowspan="1" colspan="1">50</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">People with newly diagnosed non-MDR tuberculosis recorded in the national database who received cash during treatment</td><td valign="top" align="left" rowspan="1" colspan="1">People with newly diagnosed non-MDR tuberculosis recorded in the national database who were eligible for cash interventions, but only started to receive them after treatment due to administrative delays</td></tr></tbody></table><table-wrap-foot><p>DOTS: directly observed therapy, short course; HIV: human immunodeficiency virus; MDR: multidrug resistant; NR: not reported.</p></table-wrap-foot></table-wrap><p>One study focused on migrant workers, a high-risk group within an urban centre.<xref rid="R19" ref-type="bibr"><sup>19</sup></xref> The remaining studies evaluated all tuberculosis patients identified within a given geographic or clinical service area. The control groups were either patients randomized to the non-intervention group,<xref rid="R15" ref-type="bibr"><sup>15</sup></xref> living in a non-intervention area,<xref rid="R17" ref-type="bibr"><sup>17</sup></xref><sup>,</sup><xref rid="R19" ref-type="bibr"><sup>19</sup></xref> historical controls from the same population before the implementation of the intervention,<xref rid="R16" ref-type="bibr"><sup>16</sup></xref><sup>,</sup><xref rid="R18" ref-type="bibr"><sup>18</sup></xref><sup>,</sup><xref rid="R21" ref-type="bibr"><sup>21</sup></xref> eligible for the intervention, but not yet receiving cash, because of administrative delay,<xref rid="R22" ref-type="bibr"><sup>22</sup></xref> or not eligible for the intervention, because of insufficient financial need.<xref rid="R20" ref-type="bibr"><sup>20</sup></xref></p><p>Prevalence of HIV seropositivity among the study populations was 0&#x02013;15% in the six studies reporting the outcome.<xref rid="R15" ref-type="bibr"><sup>15</sup></xref><sup>,16.14,</sup><xref rid="R17" ref-type="bibr"><sup>17</sup></xref><sup>,</sup><xref rid="R18" ref-type="bibr"><sup>18</sup></xref><sup>,</sup><xref rid="R22" ref-type="bibr"><sup>22</sup></xref> Patients with MDR/XDR tuberculosis were excluded from four studies,<xref rid="R16" ref-type="bibr"><sup>16</sup></xref><sup>,</sup><xref rid="R18" ref-type="bibr"><sup>18</sup></xref><sup>,</sup><xref rid="R19" ref-type="bibr"><sup>19</sup></xref><sup>,</sup><xref rid="R22" ref-type="bibr"><sup>22</sup></xref> two studies reported low prevalence (1&#x02013;9%),<xref rid="R15" ref-type="bibr"><sup>15</sup></xref><sup>,</sup><xref rid="R20" ref-type="bibr"><sup>20</sup></xref> while two did not report on drug susceptibility.<xref rid="R17" ref-type="bibr"><sup>17</sup></xref><sup>,</sup><xref rid="R21" ref-type="bibr"><sup>21</sup></xref> Five studies reported free care for tuberculosis,<xref rid="R15" ref-type="bibr"><sup>15</sup></xref><sup>,</sup><xref rid="R17" ref-type="bibr"><sup>17</sup></xref><sup>,</sup><xref rid="R19" ref-type="bibr"><sup>19</sup></xref><sup>,</sup><xref rid="R21" ref-type="bibr"><sup>21</sup></xref><sup>,</sup><xref rid="R22" ref-type="bibr"><sup>22</sup></xref> with the others not specifically commenting on the cost of care.<xref rid="R16" ref-type="bibr"><sup>16</sup></xref><sup>,</sup><xref rid="R18" ref-type="bibr"><sup>18</sup></xref><sup>,</sup><xref rid="R20" ref-type="bibr"><sup>20</sup></xref> Participants in six studies received the WHO recommended directly observed therapy, short-course.<xref rid="R24" ref-type="bibr"><sup>24</sup></xref></p></sec><sec><title>Tuberculosis-specific interventions</title><p>In total, seven studies evaluated tuberculosis-specific cash transfer interventions (<xref rid="T2" ref-type="table">Table&#x000a0;2</xref>).<xref rid="R15" ref-type="bibr"><sup>15</sup></xref><sup>&#x02013;</sup><xref rid="R21" ref-type="bibr"><sup>21</sup></xref> Six of these studies were at least partially conditional on clinic attendance or treatment completion,<xref rid="R15" ref-type="bibr"><sup>15</sup></xref><sup>&#x02013;</sup><xref rid="R20" ref-type="bibr"><sup>20</sup></xref> and one did not report whether the intervention was conditional.<xref rid="R21" ref-type="bibr"><sup>21</sup></xref> Four studies described an additional transportation reimbursement.<xref rid="R17" ref-type="bibr"><sup>17</sup></xref><sup>&#x02013;</sup><xref rid="R19" ref-type="bibr"><sup>19</sup></xref><sup>,</sup><xref rid="R21" ref-type="bibr"><sup>21</sup></xref></p><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Type of cash transfer intervention of included studies in the systematic review on cash interventions to improve tuberculosis clinical outcomes, 1991&#x02013;2017</title></caption><table frame="hsides" rules="groups"><col width="56" span="1"/><col width="84" span="1"/><col width="84" span="1"/><col width="61" span="1"/><col width="54" span="1"/><col width="54" span="1"/><col width="87" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Author, year</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Cash transfer intervention</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Conditional intervention; method of cash delivery</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Maximum cash, Int$<sup>a</sup></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Average cash, Int$<sup>a</sup></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Average cash as percent of annual income<sup>b</sup></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Additional interventions<sup>c</sup></th></tr></thead><tbody><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><bold>Tuberculosis-specific interventions</bold></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Farmer et al.,<xref rid="R17" ref-type="bibr"><sup>17</sup></xref> 1991</td><td valign="top" align="left" rowspan="1" colspan="1">Monthly cash transfer and travel reimbursement</td><td valign="top" align="left" rowspan="1" colspan="1">Mixed: travel reimbursement conditional on clinic attendance, monthly transfer not conditional, because clinic staff would come to the homes of the patients missing clinic visits; cash</td><td valign="top" align="center" rowspan="1" colspan="1">900</td><td valign="top" align="center" rowspan="1" colspan="1">900</td><td valign="top" align="center" rowspan="1" colspan="1">173</td><td valign="top" align="left" rowspan="1" colspan="1">Daily visits by community health worker during first month. Food supplements for first 3&#x000a0;months. If the patient did not attend the appointment, someone from the clinic went to the household to investigate</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Chirico et al.,<xref rid="R20" ref-type="bibr"><sup>20</sup></xref> 2011</td><td valign="top" align="left" rowspan="1" colspan="1">Monthly cash during period of treatment equal to low civil service salary.<break/>For patients not otherwise protected by other social safety net benefits</td><td valign="top" align="left" rowspan="1" colspan="1">Yes: clinic visits; cash delivered by the bank employee after the patient presented documentation of programme enrolment</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">None</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Rocha et al.,<xref rid="R21" ref-type="bibr"><sup>21</sup></xref> 2011</td><td valign="top" align="left" rowspan="1" colspan="1">Cash transfers for transportation, poverty reduction, and other tuberculosis-associated costs </td><td valign="top" align="left" rowspan="1" colspan="1">NR</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td><td valign="top" align="center" rowspan="1" colspan="1">291</td><td valign="top" align="center" rowspan="1" colspan="1">17 (5.5)<sup>d</sup></td><td valign="top" align="left" rowspan="1" colspan="1">Microcredit loans, vocational training, microenterprise activities (e.g. raising animals, home-based manufacturing), food transfers, home visits, community workshops, psychological assessment</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ciobanu et al.,<xref rid="R18" ref-type="bibr"><sup>18</sup></xref> 2014</td><td valign="top" align="left" rowspan="1" colspan="1">Combination of smaller monthly cash, larger cash at treatment completion, and variable transport reimbursement</td><td valign="top" align="left" rowspan="1" colspan="1">Yes: clinic visits and/or treatment completion; NR</td><td valign="top" align="center" rowspan="1" colspan="1">773</td><td valign="top" align="center" rowspan="1" colspan="1">489</td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td valign="top" align="left" rowspan="1" colspan="1">Vouchers for food/hygiene products, other support (clothes, wood for cooking). Provided to only a subset of the intervention group</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Lu et al.,<xref rid="R19" ref-type="bibr"><sup>19</sup></xref> 2015</td><td valign="top" align="left" rowspan="1" colspan="1">Monthly cash transfer and transportation subsidy</td><td valign="top" align="left" rowspan="1" colspan="1">Yes: clinic visits; cash delivered by the programme staff at the community health centre or district centre for disease control</td><td valign="top" align="center" rowspan="1" colspan="1">253</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">None</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ukwaja et al.,<xref rid="R16" ref-type="bibr"><sup>16</sup></xref> 2017</td><td valign="top" align="left" rowspan="1" colspan="1">Monthly cash transfer equivalent to median direct cost for tuberculosis care. Appointments for tuberculosis patients receiving cash arranged to not coincide with the control group</td><td valign="top" align="left" rowspan="1" colspan="1">Yes: clinic visits; cash delivered at the clinic by the trained staff member</td><td valign="top" align="center" rowspan="1" colspan="1">193</td><td valign="top" align="center" rowspan="1" colspan="1">193</td><td valign="top" align="center" rowspan="1" colspan="1">11</td><td valign="top" align="left" rowspan="1" colspan="1">None</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Wingfield et al.,<xref rid="R15" ref-type="bibr"><sup>15</sup></xref> 2017</td><td valign="top" align="left" rowspan="1" colspan="1">Cash transfers throughout treatment to defray average household tuberculosis-associated costs, estimated to be 10% annual household income in this setting</td><td valign="top" align="left" rowspan="1" colspan="1">Yes: details unspecified; deposit into bank account</td><td valign="top" align="center" rowspan="1" colspan="1">436</td><td valign="top" align="center" rowspan="1" colspan="1">355</td><td valign="top" align="center" rowspan="1" colspan="1">13 (3.6)<sup>d</sup></td><td valign="top" align="left" rowspan="1" colspan="1">Household visits with education on tuberculosis transmission, treatment, and preventive therapy and on household finances. Community meetings for information, support, empowerment and stigma reduction</td></tr><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><bold>Tuberculosis-sensitive interventions</bold></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Torrens et al.,<xref rid="R22" ref-type="bibr"><sup>22</sup></xref> 2016</td><td valign="top" align="left" rowspan="1" colspan="1">Monthly cash to female head of household as part of <italic>Bolsa Familia</italic> programme</td><td valign="top" align="left" rowspan="1" colspan="1">Yes:<break/>1) Attendance at prenatal, postnatal monitoring sessions<break/>2) Nutrition and vaccine monitoring for children<break/>3) School attendance;<break/>Withdrawal using designated debit card distributed by programme</td><td valign="top" align="center" rowspan="1" colspan="1">222</td><td valign="top" align="center" rowspan="1" colspan="1">101</td><td valign="top" align="center" rowspan="1" colspan="1">3.1</td><td valign="top" align="left" rowspan="1" colspan="1">None</td></tr></tbody></table><table-wrap-foot><p>Int$: international dollars; NA: not available; NR: not reported.</p><p><sup>a</sup> We converted the average amount of cash received per patient into Int$ purchasing power parity conversion factor, and then adjusted for inflation into 2016 dollars with the local inflation conversion factor.<xref rid="R11" ref-type="bibr"><sup>11</sup></xref></p><p><sup>b</sup> Estimated percentage of annual individual income, unless otherwise specified</p><p><sup>c</sup> Additional interventions did not involve cash.</p><p><sup>d</sup> Reported percentage of annual household income.</p></table-wrap-foot></table-wrap><p>Four studies did not report the average amount of cash received by patients in the intervention group. We contacted the authors of these studies and authors of two studies provided the amount,<xref rid="R16" ref-type="bibr"><sup>16</sup></xref><sup>,</sup><xref rid="R18" ref-type="bibr"><sup>18</sup></xref> while this information was not available for other studies.<xref rid="R19" ref-type="bibr"><sup>19</sup></xref><sup>,</sup><xref rid="R20" ref-type="bibr"><sup>20</sup></xref> The average amount of cash distributed ranged from Int$&#x000a0;193&#x02013;858. Two studies chose the amount of cash based on previous work estimating local tuberculosis-associated household costs,<xref rid="R15" ref-type="bibr"><sup>15</sup></xref><sup>,</sup><xref rid="R16" ref-type="bibr"><sup>16</sup></xref> including the CRESIPT project in Peru, the only identified randomized control trial.<xref rid="R15" ref-type="bibr"><sup>15</sup></xref> The CRESIPT project distributed cash using bank deposit (hypothesizing that opening a bank account was empowering to the study subjects),<xref rid="R15" ref-type="bibr"><sup>15</sup></xref> whereas other studies used actual cash<xref rid="R16" ref-type="bibr"><sup>16</sup></xref><sup>,</sup><xref rid="R17" ref-type="bibr"><sup>17</sup></xref><sup>,</sup><xref rid="R19" ref-type="bibr"><sup>19</sup></xref><sup>,</sup><xref rid="R20" ref-type="bibr"><sup>20</sup></xref> or did not report method of delivery.<xref rid="R18" ref-type="bibr"><sup>18</sup></xref><sup>,</sup><xref rid="R21" ref-type="bibr"><sup>21</sup></xref> Four studies included some additional non-cash co-intervention, including home visits, community meetings, food vouchers and psychological intervention.<xref rid="R15" ref-type="bibr"><sup>15</sup></xref><sup>,</sup><xref rid="R17" ref-type="bibr"><sup>17</sup></xref><sup>,</sup><xref rid="R18" ref-type="bibr"><sup>18</sup></xref><sup>,</sup><xref rid="R21" ref-type="bibr"><sup>21</sup></xref></p></sec><sec><title>Tuberculosis-sensitive interventions</title><p>Only one study described a tuberculosis-sensitive intervention, a nation-wide retrospective cohort study in Brazil of tuberculosis patients in the <italic>Bolsa Familia</italic> programme. The programme is a monthly cash transfer to poor people that is conditional on attending antenatal care, nutrition and vaccine monitoring for their children and that their young children attend school.<xref rid="R22" ref-type="bibr"><sup>22</sup></xref> People with newly diagnosed non-MDR tuberculosis who received cash during treatment were compared to those who were eligible for cash at the time of treatment, but did not receive it, because of administrative delays. The average amount of total cash delivered to the intervention group was Int$&#x000a0;101, representing an estimated 3.1% of annual individual income. Cash could be claimed by the patient monthly using a designated bank card.</p></sec><sec><title>Outcomes</title><p>Most studies (5) reported the primary outcome of treatment success,<xref rid="R15" ref-type="bibr"><sup>15</sup></xref><sup>,</sup><xref rid="R16" ref-type="bibr"><sup>16</sup></xref><sup>,</sup><xref rid="R18" ref-type="bibr"><sup>18</sup></xref><sup>&#x02013;</sup><xref rid="R20" ref-type="bibr"><sup>20</sup></xref> one reported treatment completion<xref rid="R21" ref-type="bibr"><sup>21</sup></xref> and two reported microbiologic cure (<xref rid="T3" ref-type="table">Table&#x000a0;3</xref>).<xref rid="R17" ref-type="bibr"><sup>17</sup></xref><sup>,</sup><xref rid="R22" ref-type="bibr"><sup>22</sup></xref> Four studies controlled for potential confounders.<xref rid="R16" ref-type="bibr"><sup>16</sup></xref><sup>,</sup><xref rid="R18" ref-type="bibr"><sup>18</sup></xref><sup>,</sup><xref rid="R19" ref-type="bibr"><sup>19</sup></xref><sup>,</sup><xref rid="R22" ref-type="bibr"><sup>22</sup></xref> Two of the three studies that reported loss to follow-up found significantly less loss to follow-up in the intervention group.<xref rid="R15" ref-type="bibr"><sup>15</sup></xref><sup>,</sup><xref rid="R16" ref-type="bibr"><sup>16</sup></xref><sup>,</sup><xref rid="R18" ref-type="bibr"><sup>18</sup></xref> Of the four studies which reported mortality, none found a difference between the intervention and control groups.<xref rid="R15" ref-type="bibr"><sup>15</sup></xref><sup>&#x02013;</sup><xref rid="R18" ref-type="bibr"><sup>18</sup></xref></p><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><title>Outcomes of included studies in the systematic review on cash interventions to improve tuberculosis clinical outcomes, 1991&#x02013;2017</title></caption><table frame="hsides" rules="groups"><col width="80" span="1"/><col width="85" span="1"/><col width="99" span="1"/><col width="85" span="1"/><col width="21" span="1"/><col width="70" span="1"/><col width="106" span="1"/><col width="56" span="1"/><col width="113" span="1"/><col width="113" span="1"/><thead><tr><th rowspan="3" valign="top" align="left" scope="col" colspan="1">Author, year</th><th colspan="9" valign="top" align="center" scope="colgroup" rowspan="1">Primary outcome<hr/></th></tr><tr><th rowspan="2" valign="top" colspan="1" align="center" scope="colgroup">Outcome indicator<sup>a</sup></th><th colspan="3" valign="top" align="center" scope="colgroup" rowspan="1">Sample size<hr/></th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">No. patients of with primary outcome<hr/></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1">OR (95% CI)</th><th rowspan="2" valign="top" align="center" scope="col" colspan="1">Adjusted covariates</th><th rowspan="2" valign="top" align="center" scope="col" colspan="1">Secondary outcomes (intervention versus control)</th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">Intervention</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Control</th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">Intervention<hr/></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Control</th></tr></thead><tbody><tr><td colspan="10" valign="top" align="left" scope="col" rowspan="1"><bold>Tuberculosis-specific interventions</bold></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Farmer et al.,<xref rid="R17" ref-type="bibr"><sup>17</sup></xref> 1991</td><td valign="top" align="left" rowspan="1" colspan="1">Microbiologic cure</td><td valign="top" align="center" rowspan="1" colspan="1">30</td><td valign="top" align="center" rowspan="1" colspan="1">30</td><td colspan="2" valign="top" align="center" rowspan="1">30</td><td valign="top" align="center" rowspan="1" colspan="1">13</td><td valign="top" align="center" rowspan="1" colspan="1">79.08 (4.42&#x02013;1&#x02009;413.33)</td><td valign="top" align="left" rowspan="1" colspan="1">None</td><td valign="top" align="left" rowspan="1" colspan="1">Sputum positivity at 6&#x000a0;months (0% vs 13%); pulmonary symptoms at 1&#x000a0;year (7% vs 43%); weight gained during first year (10.4 lbs vs 1.7 lbs); return to work after 1&#x000a0;year (93% vs 47%); 18-month mortality (0% vs 10%)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Chirico et al.,<xref rid="R20" ref-type="bibr"><sup>20</sup></xref> 2011</td><td valign="top" align="left" rowspan="1" colspan="1">Treatment success</td><td valign="top" align="center" rowspan="1" colspan="1">804</td><td valign="top" align="center" rowspan="1" colspan="1">847</td><td colspan="2" valign="top" align="center" rowspan="1">750</td><td valign="top" align="center" rowspan="1" colspan="1">666</td><td valign="top" align="center" rowspan="1" colspan="1">1.19 (1.03&#x02013;1.37)</td><td valign="top" align="left" rowspan="1" colspan="1">None</td><td valign="top" align="left" rowspan="1" colspan="1">None</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Rocha et al.,<xref rid="R21" ref-type="bibr"><sup>21</sup></xref> 2011</td><td valign="top" align="left" rowspan="1" colspan="1">Treatment completion</td><td valign="top" align="center" rowspan="1" colspan="1">307</td><td valign="top" align="center" rowspan="1" colspan="1">1554</td><td colspan="2" valign="top" align="center" rowspan="1">298</td><td valign="top" align="center" rowspan="1" colspan="1">1414</td><td valign="top" align="center" rowspan="1" colspan="1">3.28 (1.65&#x02013;6.51)</td><td valign="top" align="left" rowspan="1" colspan="1">None</td><td valign="top" align="left" rowspan="1" colspan="1">Health insurance registration (98% vs 36%); contact screening (96% vs 82%); rapid MDR-tuberculosis testing (92% vs 67%); HIV testing (97% vs 31%); contact preventive therapy initiation (88% vs 39%) and completion (87% vs 27%)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ciobanu et al.,<xref rid="R18" ref-type="bibr"><sup>18</sup></xref> 2014</td><td valign="top" align="left" rowspan="1" colspan="1">Treatment success</td><td valign="top" align="center" rowspan="1" colspan="1">2378</td><td valign="top" align="center" rowspan="1" colspan="1">2492</td><td colspan="2" valign="top" align="center" rowspan="1">2081</td><td valign="top" align="center" rowspan="1" colspan="1">1964</td><td valign="top" align="center" rowspan="1" colspan="1">2.00 (1.61&#x02013;2.22)<sup>b</sup></td><td valign="top" align="left" rowspan="1" colspan="1">Place of residence, sex, age, occupation, homelessness, HIV, type of tuberculosis</td><td valign="top" align="left" rowspan="1" colspan="1">Treatment failure (2% vs 5%); loss to follow-up (5% vs 10%); death (5% vs 6%)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Lu et al.,<xref rid="R19" ref-type="bibr"><sup>19</sup></xref> 2015</td><td valign="top" align="left" rowspan="1" colspan="1">Treatment success</td><td valign="top" align="center" rowspan="1" colspan="1">3290</td><td valign="top" align="center" rowspan="1" colspan="1">2413</td><td colspan="2" valign="top" align="center" rowspan="1">NR</td><td valign="top" align="center" rowspan="1" colspan="1">NR</td><td valign="top" align="center" rowspan="1" colspan="1">1.65 (1.40&#x02013;1.95)<sup>b</sup></td><td valign="top" align="left" rowspan="1" colspan="1">Gender, age, occupation, per capita GDP of district, density of population, tuberculosis specialists per 100 patients</td><td valign="top" align="left" rowspan="1" colspan="1">None</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ukwaja et al.,<xref rid="R16" ref-type="bibr"><sup>16</sup></xref> 2017</td><td valign="top" align="left" rowspan="1" colspan="1">Treatment success</td><td valign="top" align="center" rowspan="1" colspan="1">121</td><td valign="top" align="center" rowspan="1" colspan="1">173</td><td colspan="2" valign="top" align="center" rowspan="1">104</td><td valign="top" align="center" rowspan="1" colspan="1">123</td><td valign="top" align="center" rowspan="1" colspan="1">2.30 (1.20&#x02013;4.30)<sup>b</sup></td><td valign="top" align="left" rowspan="1" colspan="1">Sex, age, rural/urban residence, new/previously treated tuberculosis, HIV, smear-positivity</td><td valign="top" align="left" rowspan="1" colspan="1">Loss to follow-up (5% vs 20%); transferred out (1% vs 0%); death (7% vs 6%); smear negative at 2&#x000a0;months (88 vs 92)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Wingfield et al.,<xref rid="R15" ref-type="bibr"><sup>15</sup></xref> 2017</td><td valign="top" align="left" rowspan="1" colspan="1">Treatment success</td><td valign="top" align="center" rowspan="1" colspan="1">135</td><td valign="top" align="center" rowspan="1" colspan="1">147</td><td colspan="2" valign="top" align="center" rowspan="1">87</td><td valign="top" align="center" rowspan="1" colspan="1">78</td><td valign="top" align="center" rowspan="1" colspan="1">1.60 (0.99&#x02013;2.59)</td><td valign="top" align="left" rowspan="1" colspan="1">None</td><td valign="top" align="left" rowspan="1" colspan="1">Loss to follow-up (16% vs 18%); death (4% vs 4%)</td></tr><tr><td colspan="10" valign="top" align="left" scope="col" rowspan="1"><bold>Tuberculosis-sensitive interventions</bold></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Torrens et al.,<xref rid="R22" ref-type="bibr"><sup>22</sup></xref> 2016</td><td valign="top" align="left" rowspan="1" colspan="1">Microbiologic cure</td><td valign="top" align="center" rowspan="1" colspan="1">5788</td><td valign="top" align="center" rowspan="1" colspan="1">1467</td><td colspan="2" valign="top" align="center" rowspan="1">4752<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1128</td><td valign="top" align="center" rowspan="1" colspan="1">1.07 (1.04&#x02013;1.11)<sup>b</sup></td><td valign="top" align="left" rowspan="1" colspan="1">Age, ethnicity, diabetes mellitus, HIV, extrapulmonary tuberculosis, self-administered treatment, rural area, number of rooms in house, inappropriate floor material, baseline household monthly per capita income &#x0003c;&#x02009;US$20, illiteracy</td><td valign="top" align="left" rowspan="1" colspan="1">None</td></tr></tbody></table><table-wrap-foot><p>CI: confidence interval; GDP: gross domestic product; HIV: human immunodeficiency virus; lbs: pounds; MDR: multidrug resistant; NR: not reported; OR: odds ratio; US$: United States dollars.</p><p><sup>a</sup> The definitions of the outcomes were: treatment success was positive clinical outcome; treatment completion was if a study did not report treatment success; and microbiologic cure was if a study did not report treatment success or treatment completion.</p><p><sup>b</sup> Derived from multivariable regression models.</p></table-wrap-foot></table-wrap></sec><sec><title>Bias</title><p><xref rid="T4" ref-type="table">Table&#x000a0;4</xref> shows the risk of bias within individual observational studies and three studies met criteria for high overall risk of bias.<xref rid="R17" ref-type="bibr"><sup>17</sup></xref><sup>,</sup><xref rid="R20" ref-type="bibr"><sup>20</sup></xref><sup>,</sup><xref rid="R21" ref-type="bibr"><sup>21</sup></xref> We deemed the randomized control trial<xref rid="R15" ref-type="bibr"><sup>15</sup></xref> not to have a high overall risk of bias, as only the domain attrition showed high risk: 37% (105/282) of patients were lost to follow-up or not evaluated. The other six domains had a low risk. The funnel plot of studies included in meta-analysis did not show evidence of publication bias (<xref ref-type="fig" rid="F2">Fig.&#x000a0;2</xref>).</p><table-wrap id="T4" orientation="portrait" position="float"><label>Table 4</label><caption><title>Bias within included observational studies in the systematic review on cash interventions to improve tuberculosis clinical outcomes, 1991&#x02013;2017</title></caption><table frame="hsides" rules="groups"><col width="127" span="1"/><col width="70" span="1"/><col width="94" span="1"/><col width="68" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Study, year</th><th colspan="3" valign="top" align="center" scope="colgroup" rowspan="1">Category, no. of stars<hr/></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">Selection<sup>a</sup></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Comparability<sup>b</sup></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Outcome<sup>c</sup></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Farmer et al.,<xref rid="R17" ref-type="bibr"><sup>17</sup></xref> 1991</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">2</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Chirico et al.,<xref rid="R20" ref-type="bibr"><sup>20</sup></xref> 2011</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">1</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Rocha et al.,<xref rid="R21" ref-type="bibr"><sup>21</sup></xref> 2011</td><td valign="top" align="center" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ciobanu et al.,<xref rid="R18" ref-type="bibr"><sup>18</sup></xref> 2014</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">2</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Lu et al.,<xref rid="R19" ref-type="bibr"><sup>19</sup></xref> 2015 </td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">2</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Torrens et al.,<xref rid="R22" ref-type="bibr"><sup>22</sup></xref> 2016</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">3</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ukwaja et al.,<xref rid="R16" ref-type="bibr"><sup>16</sup></xref> 2017</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">2</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup> A study could be awarded a maximum of four stars for this category.</p><p><sup>b</sup> A study could be awarded a maximum of two stars for this category.</p><p><sup>c</sup> A study could be awarded a maximum of two stars for this category.</p><p>Note: We used Newcastle-Ottawa Scale to assess bias in observational studies. The more stars the study received the lower the risk of bias.</p></table-wrap-foot></table-wrap><fig id="F2" fig-type="figure" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Publication bias of studies included in the meta-analysis on cash interventions to improve tuberculosis clinical outcomes, 1991&#x02013;2017</p></caption><p>OR: odds ratio; SE: standard error.</p><p>Note: The dashed vertical line represents the summary OR generated through random effects meta-analysis.</p><graphic xlink:href="BLT.18.208959-F2"/></fig></sec><sec><title>Summary effect measures</title><p><xref ref-type="fig" rid="F3">Fig.&#x000a0;3</xref> shows the forest plot of the remaining tuberculosis-specific studies after excluding studies at high overall risk of bias. Patients receiving tuberculosis-specific cash transfer were more likely to have a clinical positive outcome than patients in the control groups (OR: 1.77; 95% confidence interval: 1.57&#x02013;2.01), with <italic>I</italic><sup>2</sup>&#x02009;=&#x02009;0% (<italic>Q</italic>&#x000a0;test <italic>P</italic>&#x02009;=&#x02009;0.44).</p><fig id="F3" fig-type="figure" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Likelihood of a positive clinical outcome for tuberculosis-specific cash interventions to improve tuberculosis clinical outcomes, 1991&#x02013;2017</p></caption><p>CI: confidence interval; OR: odds ratio.</p><p>Note: We excluded three studies with a high overall risk of bias.<xref rid="R17" ref-type="bibr"><sup>17</sup></xref><sup>,</sup><xref rid="R20" ref-type="bibr"><sup>20</sup></xref><sup>,</sup><xref rid="R21" ref-type="bibr"><sup>21</sup></xref></p><graphic xlink:href="BLT.18.208959-F3"/></fig></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>The findings of this systematic review and meta-analysis suggest that cash transfer interventions for patients in low- and middle-income countries initiating tuberculosis treatment may improve clinical outcomes. All studies reported improvement in treatment outcomes. However, the overall evidence is weak because we only identified one eligible randomized control trial. Additionally, half of the studies included some non-cash co-intervention and thus some of the positive effects seen may be related to the pooled effects of cash and non-cash interventions.</p><p>There are several possible mechanisms by which cash transfer interventions may improve clinical outcomes for tuberculosis patients during treatment.<xref rid="R6" ref-type="bibr"><sup>6</sup></xref><sup>,</sup><xref rid="R25" ref-type="bibr"><sup>25</sup></xref> Both tuberculosis-specific and tuberculosis-sensitive cash transfer interventions can act as direct poverty-reduction measures by offsetting costs caused by the disease. These costs include both direct costs of treatment such as clinic fees, medication costs, travel and/or food, as well as indirect costs incurred through loss of wages. In particular, catastrophic costs, defined as tuberculosis-related costs which exceed 20% of the household&#x02019;s annual income, have been associated with adverse clinical outcomes.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="R2" ref-type="bibr"><sup>2</sup></xref><sup>,</sup><xref rid="R26" ref-type="bibr"><sup>26</sup></xref> Two studies have found that, on average, a person with tuberculosis in a low- and middle-income country will experience catastrophic costs as a result of the illness.<xref rid="R2" ref-type="bibr"><sup>2</sup></xref><sup>,</sup><xref rid="R27" ref-type="bibr"><sup>27</sup></xref> In this review, one tuberculosis-specific intervention provided cash equivalent to 173% of estimated annual individual income,<xref rid="R17" ref-type="bibr"><sup>17</sup></xref> four provided cash equivalent to 10&#x02013;20% of estimated annual individual income,<xref rid="R15" ref-type="bibr"><sup>15</sup></xref><sup>,</sup><xref rid="R16" ref-type="bibr"><sup>16</sup></xref><sup>,</sup><xref rid="R18" ref-type="bibr"><sup>18</sup></xref><sup>,</sup><xref rid="R21" ref-type="bibr"><sup>21</sup></xref> and two of these studies also reported the intervention as percentage of annual household income, between 3&#x02013;6%.<xref rid="R15" ref-type="bibr"><sup>15</sup></xref><sup>,</sup><xref rid="R21" ref-type="bibr"><sup>21</sup></xref> The single tuberculosis-sensitive intervention we identified provided cash equivalent to 3.8% of estimated annual individual income. The difference between tuberculosis-specific and tuberculosis-sensitive interventions may reflect the findings that sensitive interventions are less likely to be effective and affordable by countries for offsetting tuberculosis-associated catastrophic costs than specific interventions.<xref rid="R27" ref-type="bibr"><sup>27</sup></xref> However, tuberculosis-sensitive interventions also have the advantage of a broader poverty reduction impact, which might improve household economic resilience before a household member develops active tuberculosis infection.</p><p>Beyond simply offsetting costs, cash transfer interventions may also serve as an additional incentive for health-seeking behaviour, particularly when distribution is conditional on clinical follow-up or medication adherence.<xref rid="R28" ref-type="bibr"><sup>28</sup></xref><sup>&#x02013;</sup><xref rid="R30" ref-type="bibr"><sup>30</sup></xref> Several systematic reviews have found a positive effect of conditional cash transfers in low- and middle-income countries on health behaviours and outcomes, including increased use of preventative services, improved childhood nutritional status, decreased self-reported episodes of illness and decreased HIV prevalence.<xref rid="R25" ref-type="bibr"><sup>25</sup></xref><sup>,</sup><xref rid="R30" ref-type="bibr"><sup>30</sup></xref><sup>,</sup><xref rid="R31" ref-type="bibr"><sup>31</sup></xref> Another systematic review found that the impact of unconditional cash transfers on health services use and health outcomes was uncertain.<xref rid="R28" ref-type="bibr"><sup>28</sup></xref> None of the interventions we identified had a completely unconditional cash transfer intervention. The incentive of a conditional intervention may be particularly important in tuberculosis care, where consistent adherence to a multiple-drug regimen for a prolonged treatment course is essential for optimal treatment outcomes. However, a meta-analysis of the effect of incentives and/or enablers on medication adherence in tuberculosis was largely inconclusive, but primarily identified studies in high-income countries, where financial interventions may have less effect.<xref rid="R32" ref-type="bibr"><sup>32</sup></xref> Tuberculosis-sensitive interventions are likely to lack a tuberculosis-specific incentive, although they may include other conditional elements unrelated to tuberculosis, as in the case of the <italic>Bolsa Familia</italic> programme.<xref rid="R22" ref-type="bibr"><sup>22</sup></xref></p><p>The studies showed substantial heterogeneity in study design. However, there was no measured heterogeneity within the subset of studies with tuberculosis-specific interventions that were not at high overall risk of bias. Although factors related to the population, setting and intervention could cause heterogeneity in the effect size of the interventions, the available information from the limited number of studies did not allow us to determine the impact of these variables.</p><p>Whether cash transfers or goods and services, such as direct provision of food, vocational training, psychologic support and housing programmes, are preferable to improve health-related and other outcomes is currently under debate.<xref rid="R33" ref-type="bibr"><sup>33</sup></xref><sup>&#x02013;</sup><xref rid="R35" ref-type="bibr"><sup>35</sup></xref> A recent meta-analysis found that non-cash socioeconomic interventions, predominantly food provision, may improve clinical outcomes in active tuberculosis.<xref rid="R36" ref-type="bibr"><sup>36</sup></xref> To better understand which forms of social protection are most effective at improving clinical outcomes for tuberculosis, non-cash strategies should be studied comparatively and in combination with cash transfer interventions.</p><p>While beyond the scope of this review, the impact of cash transfer interventions on household and national or subnational outcomes, like contact screening and overall tuberculosis incidence, must also be considered. For example, a multivariable analysis found that municipalities in Brazil with higher coverage by the <italic>Bolsa Familia</italic> programme had a significant reduction in tuberculosis incidence compared to those with lower coverage.<xref rid="R37" ref-type="bibr"><sup>37</sup></xref></p><p>In conclusion, we found some evidence that cash transfer interventions improve treatment outcomes in patients with active pulmonary tuberculosis in low- and middle-income countries, although the overall quality of this evidence is low. These findings support calls by WHO and others to incorporate cash transfer interventions into social protection schemes within tuberculosis treatment programmes.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="R6" ref-type="bibr"><sup>6</sup></xref> In addition, high-quality research is needed to better understand the effectiveness of tuberculosis-specific and tuberculosis-sensitive cash transfer interventions, including understanding of the optimal amount, conditional feature, delivery method and implementation strategy.</p></sec></body><back><ack><title>Acknowledgements</title><p>JJ, LBN and JW contributed equally to this work.</p></ack><fn-group><title>Competing interests:</title><fn fn-type="financial-disclosure"><p>None declared.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><mixed-citation publication-type="web">Global tuberculosis report. Geneva: World Health Organization; 2017. Available from: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/handle/10665/259366/9789241565516-eng.pdf?sequence=1">http://apps.who.int/iris/bitstream/handle/10665/259366/9789241565516-eng.pdf?sequence=1</ext-link> [cited 2017 Aug 16].</mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal"><string-name><surname>Tanimura</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Jaramillo</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Weil</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Raviglione</surname>
<given-names>M</given-names></string-name>, <string-name><surname>L&#x000f6;nnroth</surname>
<given-names>K</given-names></string-name>. <article-title>Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review.</article-title>
<source>Eur Respir J</source>. <year>2014</year>
<month>6</month>;<volume>43</volume>(<issue>6</issue>):<fpage>1763</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1183/09031936.00193413</pub-id><pub-id pub-id-type="pmid">24525439</pub-id></mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="web">Global strategy and targets for tuberculosis prevention, care and control after 2015: report by the Secretariat. Geneva: World Health Organization; 2013. Available from: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/gb/ebwha/pdf_files/EB134/B134_12-en.pdf?ua=1">http://apps.who.int/gb/ebwha/pdf_files/EB134/B134_12-en.pdf?ua=1</ext-link> [cited 2018 May 12].</mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="book"><source>Combating poverty and inequality: structural change, social policy and politics.</source>
<publisher-loc>Geneva</publisher-loc>: <publisher-name>United Nations Research Institute for Social Development</publisher-name>; <year>2010</year>.</mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="book"><string-name><surname>Garcia</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Moore</surname>
<given-names>CM</given-names></string-name>. <source>The cash dividend: the rise of cash transfer programs in sub-Saharan Africa.</source>
<publisher-loc>Washington, DC</publisher-loc>: <publisher-name>The World Bank</publisher-name>; <year>2012</year>
<pub-id pub-id-type="doi">10.1596/978-0-8213-8897-6</pub-id></mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="journal"><string-name><surname>Boccia</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Pedrazzoli</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Wingfield</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Jaramillo</surname>
<given-names>E</given-names></string-name>, <string-name><surname>L&#x000f6;nnroth</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Lewis</surname>
<given-names>J</given-names></string-name>, <etal>et al.</etal>
<article-title>Towards cash transfer interventions for tuberculosis prevention, care and control: key operational challenges and research priorities.</article-title>
<source>BMC Infect Dis</source>. <year>2016</year>
<month>6</month>
<day>21</day>;<volume>16</volume>(<issue>1</issue>):<fpage>307</fpage>. <pub-id pub-id-type="doi">10.1186/s12879-016-1529-8</pub-id><pub-id pub-id-type="pmid">27329161</pub-id></mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="journal"><string-name><surname>Boccia</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Hargreaves</surname>
<given-names>J</given-names></string-name>, <string-name><surname>L&#x000f6;nnroth</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Jaramillo</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Weiss</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Uplekar</surname>
<given-names>M</given-names></string-name>, <etal>et al.</etal>
<article-title>Cash transfer and microfinance interventions for tuberculosis control: review of the impact evidence and policy implications.</article-title>
<source>Int J Tuberc Lung Dis</source>. <year>2011</year>
<month>6</month>;<volume>15</volume>(<issue>6</issue>) <supplement>Suppl 2</supplement>:<fpage>37</fpage>&#x02013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.5588/ijtld.10.0438</pub-id><pub-id pub-id-type="pmid">21740658</pub-id></mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="journal"><string-name><surname>Hutton</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Salanti</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Caldwell</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Chaimani</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Schmid</surname>
<given-names>CH</given-names></string-name>, <string-name><surname>Cameron</surname>
<given-names>C</given-names></string-name>, <etal>et al.</etal>
<article-title>The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.</article-title>
<source>Ann Intern Med</source>. <year>2015</year>
<month>6</month>
<day>2</day>;<volume>162</volume>(<issue>11</issue>):<fpage>777</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.7326/M14-2385</pub-id><pub-id pub-id-type="pmid">26030634</pub-id></mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="other">Fantom NJ, Serajuddin U. The World Bank's classification of countries by income. Policy Research working paper; no. WPS 7528. Washington, DC: World Bank Group; 2016.</mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="web">Definitions and reporting framework for tuberculosis: Geneva: World Health Organization; 2013 Available from: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/handle/10665/79199/9789241505345_eng.pdf?sequence=1">http://apps.who.int/iris/bitstream/handle/10665/79199/9789241505345_eng.pdf?sequence=1</ext-link> [cited 2017 Aug 16].</mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="web">World development indicators [internet]. Washington, DC: The World Bank; 2018. Available from: <ext-link ext-link-type="uri" xlink:href="https://datacatalog.worldbank.org/dataset/world-development-indicators">https://datacatalog.worldbank.org/dataset/world-development-indicators</ext-link> [cited 2018 Jan 5].</mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="journal"><string-name><surname>L&#x000f6;nnroth</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Jaramillo</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Williams</surname>
<given-names>BG</given-names></string-name>, <string-name><surname>Dye</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Raviglione</surname>
<given-names>M</given-names></string-name>. <article-title>Drivers of tuberculosis epidemics: the role of risk factors and social determinants.</article-title>
<source>Soc Sci Med</source>. <year>2009</year>
<month>6</month>;<volume>68</volume>(<issue>12</issue>):<fpage>2240</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.socscimed.2009.03.041</pub-id><pub-id pub-id-type="pmid">19394122</pub-id></mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="book">Higgins J, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0. [updated March 2011]. London: The Cochrane Collaboration; 2011. Available from: <ext-link ext-link-type="uri" xlink:href="http://training.cochrane.org/handbook">http://training.cochrane.org/handbook</ext-link> [cited 2017 Aug 16].</mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="web">Wells G, Shea B, O&#x02019;Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute; 2011. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp">http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp</ext-link> [cited 2018 Jan 5].</mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="journal"><string-name><surname>Wingfield</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Tovar</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Huff</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Boccia</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Montoya</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Ramos</surname>
<given-names>E</given-names></string-name>, <etal>et al.</etal>
<article-title>A randomized controlled study of socioeconomic support to enhance tuberculosis prevention and treatment, Peru.</article-title>
<source>Bull World Health Organ</source>. <year>2017</year>
<month>4</month>
<day>1</day>;<volume>95</volume>(<issue>4</issue>):<fpage>270</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.2471/BLT.16.170167</pub-id><pub-id pub-id-type="pmid">28479622</pub-id></mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="journal"><string-name><surname>Ukwaja</surname>
<given-names>KN</given-names></string-name>, <string-name><surname>Alobu</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Gidado</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Onazi</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Oshi</surname>
<given-names>DC</given-names></string-name>. <article-title>Economic support intervention improves tuberculosis treatment outcomes in rural Nigeria.</article-title>
<source>Int J Tuberc Lung Dis</source>. <year>2017</year>
<month>5</month>
<day>1</day>;<volume>21</volume>(<issue>5</issue>):<fpage>564</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.5588/ijtld.16.0741</pub-id><pub-id pub-id-type="pmid">28399972</pub-id></mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="journal"><string-name><surname>Farmer</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Robin</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ramilus</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>JY</given-names></string-name>. <article-title>Tuberculosis, poverty, and &#x0201c;compliance&#x0201d;: lessons from rural Haiti.</article-title>
<source>Semin Respir Infect</source>. <year>1991</year>
<month>12</month>;<volume>6</volume>(<issue>4</issue>):<fpage>254</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">1810004</pub-id></mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="journal"><string-name><surname>Ciobanu</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Domente</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Soltan</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Bivol</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Severin</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Plesca</surname>
<given-names>V</given-names></string-name>, <etal>et al.</etal>
<article-title>Do incentives improve tuberculosis treatment outcomes in the Republic of Moldova?</article-title>
<source>Public Health Action</source>. <year>2014</year>
<month>10</month>
<day>21</day>;<volume>4</volume>
<issue>Suppl 2</issue>:<fpage>S59</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.5588/pha.14.0047</pub-id><pub-id pub-id-type="pmid">26393100</pub-id></mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="journal"><string-name><surname>Lu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Shen</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Yuan</surname>
<given-names>Z</given-names></string-name>, <etal>et al.</etal>
<article-title>Efforts to reduce the disparity between permanent residents and temporary migrants: Stop TB experiences in Shanghai, China.</article-title>
<source>Trop Med Int Health</source>. <year>2015</year>
<month>8</month>;<volume>20</volume>(<issue>8</issue>):<fpage>1033</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1111/tmi.12512</pub-id><pub-id pub-id-type="pmid">25819348</pub-id></mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="journal"><string-name><surname>Chirico</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Kuriger</surname>
<given-names>AB</given-names></string-name>, <string-name><surname>Etchevarria</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Zerbini</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Casamajor</surname>
<given-names>ML</given-names></string-name>. <article-title>Economic subsidies for patients with tuberculosis and their relationship with treatment adherence.</article-title>
<source>Salud i Ciencia</source>. <year>2011</year>;<volume>17</volume>(<issue>8</issue>):<fpage>798</fpage>&#x02013;<lpage>801</lpage>.</mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="journal"><string-name><surname>Rocha</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Montoya</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Zevallos</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Curatola</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ynga</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Franco</surname>
<given-names>J</given-names></string-name>, <etal>et al.</etal>
<article-title>The Innovative Socioeconomic Interventions Against Tuberculosis (ISIAT) project: an operational assessment.</article-title>
<source>Int J Tuberc Lung Dis</source>. <year>2011</year>
<month>6</month>;<volume>15</volume>(<issue>6</issue>) <supplement>Suppl 2</supplement>:<fpage>50</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.5588/ijtld.10.0447</pub-id><pub-id pub-id-type="pmid">21740659</pub-id></mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="journal"><string-name><surname>Torrens</surname>
<given-names>AW</given-names></string-name>, <string-name><surname>Rasella</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Boccia</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Maciel</surname>
<given-names>EL</given-names></string-name>, <string-name><surname>Nery</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Olson</surname>
<given-names>ZD</given-names></string-name>, <etal>et al.</etal>
<article-title>Effectiveness of a conditional cash transfer programme on TB cure rate: a retrospective cohort study in Brazil.</article-title>
<source>Trans R Soc Trop Med Hyg</source>. <year>2016</year>
<month>3</month>;<volume>110</volume>(<issue>3</issue>):<fpage>199</fpage>&#x02013;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1093/trstmh/trw011</pub-id><pub-id pub-id-type="pmid">26884501</pub-id></mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="web">High burden countries [internet]. Copenhagen: United Nations Office for Project Services; 2018. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.stoptb.org/countries/tbdata.asp">http://www.stoptb.org/countries/tbdata.asp</ext-link> [cited 2017 Aug 30].</mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="journal"><article-title>An expanded DOTS framework for effective tuberculosis control.</article-title>
<source>Int J Tuberc Lung Dis</source>. <year>2002</year>
<month>5</month>;<volume>6</volume>(<issue>5</issue>):<fpage>378</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="pmid">12019913</pub-id></mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="journal"><string-name><surname>Ranganathan</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lagarde</surname>
<given-names>M</given-names></string-name>. <article-title>Promoting healthy behaviours and improving health outcomes in low and middle income countries: a review of the impact of conditional cash transfer programmes.</article-title>
<source>Prev Med</source>. <year>2012</year>
<month>11</month>;<volume>55</volume>
<issue>Suppl</issue>:<fpage>S95</fpage>&#x02013;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.ypmed.2011.11.015</pub-id><pub-id pub-id-type="pmid">22178043</pub-id></mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="journal"><string-name><surname>Wingfield</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Boccia</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Tovar</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gavino</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Zevallos</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Montoya</surname>
<given-names>R</given-names></string-name>, <etal>et al.</etal>
<article-title>Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru.</article-title>
<source>PLoS Med</source>. <year>2014</year>
<month>7</month>
<day>15</day>;<volume>11</volume>(<issue>7</issue>):<fpage>e1001675</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1001675</pub-id><pub-id pub-id-type="pmid">25025331</pub-id></mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="journal"><string-name><surname>Rudgard</surname>
<given-names>WE</given-names></string-name>, <string-name><surname>Evans</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Sweeney</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wingfield</surname>
<given-names>T</given-names></string-name>, <string-name><surname>L&#x000f6;nnroth</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Barreira</surname>
<given-names>D</given-names></string-name>, <etal>et al.</etal>
<article-title>Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study.</article-title>
<source>PLoS Med</source>. <year>2017</year>
<month>11</month>
<day>7</day>;<volume>14</volume>(<issue>11</issue>):<fpage>e1002418</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1002418</pub-id><pub-id pub-id-type="pmid">29112693</pub-id></mixed-citation></ref><ref id="R28"><label>28</label><mixed-citation publication-type="journal"><string-name><surname>Pega</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>SY</given-names></string-name>, <string-name><surname>Walter</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Pabayo</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Saith</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Lhachimi</surname>
<given-names>SK</given-names></string-name>. <article-title>Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health outcomes in low- and middle-income countries.</article-title>
<source>Cochrane Database Syst Rev</source>. <year>2017</year>
<month>11</month>
<day>15</day>;<volume>11</volume>(<issue>11</issue>):<fpage>CD011135</fpage>.<pub-id pub-id-type="pmid">29139110</pub-id></mixed-citation></ref><ref id="R29"><label>29</label><mixed-citation publication-type="journal"><string-name><surname>Owusu-Addo</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Cross</surname>
<given-names>R</given-names></string-name>. <article-title>The impact of conditional cash transfers on child health in low- and middle-income countries: a systematic review.</article-title>
<source>Int J Public Health</source>. <year>2014</year>
<month>8</month>;<volume>59</volume>(<issue>4</issue>):<fpage>609</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1007/s00038-014-0570-x</pub-id><pub-id pub-id-type="pmid">24898173</pub-id></mixed-citation></ref><ref id="R30"><label>30</label><mixed-citation publication-type="journal"><string-name><surname>Lagarde</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Haines</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Palmer</surname>
<given-names>N</given-names></string-name>. <article-title>The impact of conditional cash transfers on health outcomes and use of health services in low and middle income countries.</article-title>
<source>Cochrane Database Syst Rev</source>. <year>2009</year>
<month>10</month>
<day>7</day>; (<issue>4</issue>):<fpage>CD008137</fpage>.<pub-id pub-id-type="pmid">19821444</pub-id></mixed-citation></ref><ref id="R31"><label>31</label><mixed-citation publication-type="journal"><string-name><surname>Gopalan</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Mutasa</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Friedman</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Das</surname>
<given-names>A</given-names></string-name>. <article-title>Health sector demand-side financial incentives in low- and middle-income countries: a systematic review on demand- and supply-side effects.</article-title>
<source>Soc Sci Med</source>. <year>2014</year>
<month>1</month>;<volume>100</volume>(<issue>100</issue>):<fpage>72</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.socscimed.2013.10.030</pub-id><pub-id pub-id-type="pmid">24444841</pub-id></mixed-citation></ref><ref id="R32"><label>32</label><mixed-citation publication-type="journal"><string-name><surname>Lutge</surname>
<given-names>EE</given-names></string-name>, <string-name><surname>Wiysonge</surname>
<given-names>CS</given-names></string-name>, <string-name><surname>Knight</surname>
<given-names>SE</given-names></string-name>, <string-name><surname>Sinclair</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Volmink</surname>
<given-names>J</given-names></string-name>. <article-title>Incentives and enablers to improve adherence in tuberculosis.</article-title>
<source>Cochrane Database Syst Rev</source>. <year>2015</year>
<month>9</month>
<day>3</day>;(<issue>9</issue>):<fpage>CD007952</fpage>.<pub-id pub-id-type="pmid">26333525</pub-id></mixed-citation></ref><ref id="R33"><label>33</label><mixed-citation publication-type="journal"><string-name><surname>Cunha</surname>
<given-names>JM</given-names></string-name>. <article-title>Testing paternalism: cash versus in-kind transfers.</article-title>
<source>Am Econ J Appl Econ</source>. <year>2014</year>;<volume>6</volume>(<issue>2</issue>):<fpage>195</fpage>&#x02013;<lpage>230</lpage>. <pub-id pub-id-type="doi">10.1257/app.6.2.195</pub-id></mixed-citation></ref><ref id="R34"><label>34</label><mixed-citation publication-type="journal"><string-name><surname>Currie</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Gahvari</surname>
<given-names>F</given-names></string-name>. <article-title>Transfers in cash and in-kind: theory meets the data.</article-title>
<source>J Econ Lit</source>. <year>2008</year>;<volume>46</volume>(<issue>2</issue>):<fpage>333</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1257/jel.46.2.333</pub-id></mixed-citation></ref><ref id="R35"><label>35</label><mixed-citation publication-type="journal"><string-name><surname>Leroy</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Gadsden</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Rodr&#x000ed;guez-Ram&#x000ed;rez</surname>
<given-names>S</given-names></string-name>, <string-name><surname>de Coss&#x000ed;o</surname>
<given-names>TG</given-names></string-name>. <article-title>Cash and in-kind transfers in poor rural communities in Mexico increase household fruit, vegetable, and micronutrient consumption but also lead to excess energy consumption.</article-title>
<source>J Nutr</source>. <year>2010</year>
<month>3</month>;<volume>140</volume>(<issue>3</issue>):<fpage>612</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.3945/jn.109.116285</pub-id><pub-id pub-id-type="pmid">20089777</pub-id></mixed-citation></ref><ref id="R36"><label>36</label><mixed-citation publication-type="journal"><string-name><surname>van Hoorn</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Jaramillo</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Collins</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Gebhard</surname>
<given-names>A</given-names></string-name>, <string-name><surname>van den Hof</surname>
<given-names>S</given-names></string-name>. <article-title>The effects of psycho-emotional and socioeconomic support for tuberculosis patients on treatment adherence and treatment outcomes: a systematic review and meta-analysis.</article-title>
<source>PLoS One</source>. <year>2016</year>
<month>4</month>
<day>28</day>;<volume>11</volume>(<issue>4</issue>):<fpage>e0154095</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0154095</pub-id><pub-id pub-id-type="pmid">27123848</pub-id></mixed-citation></ref><ref id="R37"><label>37</label><mixed-citation publication-type="journal"><string-name><surname>Nery</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Rodrigues</surname>
<given-names>LC</given-names></string-name>, <string-name><surname>Rasella</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Aquino</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Barreira</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Torrens</surname>
<given-names>AW</given-names></string-name>, <etal>et al.</etal>
<article-title>Effect of Brazil&#x02019;s conditional cash transfer programme on tuberculosis incidence.</article-title>
<source>Int J Tuberc Lung Dis</source>. <year>2017</year>
<month>7</month>
<day>1</day>;<volume>21</volume>(<issue>7</issue>):<fpage>790</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.5588/ijtld.16.0599</pub-id><pub-id pub-id-type="pmid">28633704</pub-id></mixed-citation></ref></ref-list></back></article>